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CHAPTER 1

INTRODUCTION

1.1 Overview
Proteins are the workhorses of the living cell, functioning as enzymes,
messengers, structural elements, and transporters. The involvement of these major
biological molecules in processes such as metabolism, DNA replication, immunity,
locomotion, as well as their terminal position in the “central dogma” of molecular
biology motivated extensive research throughout the 20th century exploring how these
genetically-encoded chains of amino acids fold into specific structures and assume
functional roles. With this came the insight that the proteome (the set of all proteins in a
cell) is not static, but undergoing frequent modification to adapt to the changing
requirements of the cell’s intrinsically-encoded cycles, its changing context in relation to
other cells, and potentially toxic stress from the environment.
The proteome can be altered by increasing the quantity of specific proteins (by
regulated transcription and translation of genes), modifying the structure or location of
existing proteins, or removing specific proteins from the proteome via proteolytic
1

degradation. While bulk proteolysis had been known to occur in lysosomes via
autophagy, work in the 1970’s and 80’s led to the discovery of a new mechanism of
proteolysis. This mechanism required large amounts of energy, targeted attachment of
ubiquitin (a protein-based “tag”), and the proteasome, a very large proteolytic enzyme
complex. The complexity of this system, the ubiquitin-proteasome system (UPS),
underscores its ability to degrade proteins with high specificity.
It is clear that human health depends on a properly regulated and maintained
proteome, and that regulated proteolysis is essential. Many cells divide by mitosis as part
of the cell cycle during growth, development, and tissue maintenance. A primary driver
of this cycle is the fluctuation of levels of cyclin proteins, which are removed from the
proteome via regulated proteolysis (Bassermann et al., 2014). Improper cell cycle
regulation may lead to developmental defects or cancer.
Tissues are subjected to stress from mechanical strain, thermal fluctuation, free
radicals, toxins, starvation, radiation, and genetic mutations that can cause aberrations in
protein structure. Cells maintain proteostasis (protein homeostasis) in part by mounting
coordinated protein quality control (PQC) responses to stressors and by directly sensing
and attempting to correct misfolded proteins. If the first line of defense, molecular
chaperones, fails to refold a protein, it is triaged to one of several fates, including
regulated degradation by the UPS (Amm et al., 2014). Failure of PQC, including the
UPS, may lead to accumulation of misfolded or damaged proteins that interact
improperly with other cellular proteins or form aggregates and plaques. This failure is
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thought to play a major role in several diseases, including Huntington’s disease,
Alzheimer’s disease, and cancer.
Understanding the mechanisms by which ubiquitin, the proteasome, and
associated enzymes participate in the cell’s responses to changing proteomic needs may
lead to improved clinical therapies and diagnostics, as well as contribute to an emerging
field of biological research. To this end, we have used the model organism
Caenorhabditis elegans to perform studies on how ubiquitin and ubiquitin-conjugating
enzymes are involved in protein aggregation (Chapter 2) and where the proteasome
localizes within cells during aging and stress (Chapters 3 and 4). The remainder of this
chapter will provide background information common to these studies.
1.2 Ubiquitin
1.2.1 Overview
Ubiquitination is an important post-translational modification marked by
regulated covalent attachment of the 8-kDa protein ubiquitin to specific cellular protein
targets (Ciechanover, 2006). Through the action of the E1-E2-E3 series of enzymes, a
high degree of substrate specificity is attained thus affording tight spatial and temporal
control of a variety of cellular processes. Membrane protein transport (Hicke & Dunn,
2003), DNA damage repair (Hoege et al., 2002), and histone regulation (Robzyk et al.,
2000) are all known to be directly regulated by ubiquitination. The most well known fate
of ubiquitinated protein substrates is degradation by the 26S proteasome. Targeting of
substrate proteins to the proteasome for degradation requires the sequential attachment of
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at least 4 ubiquitins to form a polyubiquitin chain, each linked serially via isopeptide
bonds between the C-terminal glycine of one ubiquitin to the ε-amino group of lysine 48
(K48) on the next (Thrower et al., 2000). Thus, the ubiquitin-proteasome system allows
for specific degradation of protein targets and regulates cellular processes by controlling
the half-life of proteins in pathways such as the cell cycle (Murray, 2004). In addition to
regulating cellular pathways, the ubiquitin-proteasome system is also important in the
degradation of misfolded or damaged proteins, as part of the protein quality control
(PQC) system.
1.2.2 Ubiquitin enzymatic cascade
The ubiquitination pathway provides a great deal of control and specificity for the
process of conjugation to a target protein, as each step in the enzymatic cascade provides
an increasingly large number of enzymes with varying function. Figure 1.1A illustrates
the ubiquitin-proteasome proteolytic pathway, from the ubiquitin conjugation cascade to
proteolytic degradation by the proteasome.
Ubiquitin is a small protein 8.5 kiloDalton (kDa) in size that is highly conserved
in eukaryotes. It is highly abundant within cells, existing as free soluble monomers,
members of polyubiquitin chains, and conjugated to a wide variety of proteins.
Free cellular ubiquitin enters the conjugation cascade when “activated” by an E1
ubiquitin-activating enzyme, of which most organisms possess only one or two variants.
This initial reaction utilizes ATP to form a thiolester bond between the C-terminal glycine
of ubiquitin and the E1's active site cysteine, releasing AMP and pyrophosphate (Lake et

4

al., 2001). To transfer ubiquitin, the E1 enzyme binds to an E2 enzyme and undergoes a
conformational change to bring together the active sites of the two enzymes. A
transthiolation reaction then conjugates ubiquitin to the active-site cysteine of the E2.
The E2 enzymes for ubiquitin are ubiquitin-conjugating enzymes (UBCs).
Typically, eukaryotes contain between 15 and 40 different UBCs. Ubiquitin can be
transferred from a given UBC to any of several E3s, and a given E3 may be able to
accept ubiquitin from any of several UBCs. Specific UBCs can play a role in determining
the type of polyubiquitin chain formed on a target substrate. For example, the
Saccharomyces cerevisiae enzyme Ubc13p, in conjunction with Mms2p, catalyzes the
formation of K63-linked polyubiquitin chains (Hofmann & Pickart, 1999), while yeast
Ubc1p catalyzes the formation of K48-linked chains (Rodrigo-Brenni & Morgan, 2007).
In addition, it appears that some chain-extending UBCs cannot initiate polyubiquitination
without a previously conjugated acceptor ubiquitin (Christensen et al., 2007),
demonstrating cooperation between UBCs in protein degradation.
1.2.2.1 E3 Ubiquitin ligases
The third type of enzyme in the ubiquitination cascade are the E3 ubiquitin
ligases, which function primarily in substrate recognition. There are over 600 known
ubiquitin ligases (Li et al., 2008), most of which are of the RING (Really Interesting New
Gene) type, while a smaller subset are HECT (Homologous to the E6-AP Carboxyl
Terminus) type.

5

Figure 1.1: Ubiquitin-proteasome proteolytic pathway
A) Ubiquitin conjugation cascade. B) Proteasome structure, assembly, and function.
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RING type E3s contain RING domain or a PHD/LAP or U-box. These common
E3s function primarily as a scaffold to facilitate transfer of ubiquitin directly from the
UBC (E2) to the substrate. Substrate recognition by these ligases can occur directly by
the RING-containing polypeptide, or indirectly as in the case of multi-subunit RING
ligases such as Cullin-RING ligases.
HECT E3s accept ubiquitin directly from the E2 via a catalytic cysteine within the
HECT domain and subsequently transfer this ubiquitin to the substrate. Substrate
recognition likely occurs at the N-terminal regions of the HECT E3.
A single E2 can interact with multiple E3s, and a single E3 can interact with
multiple UBCs. Thus, an E3’s choice of interacting UBC can determine the type of
ubiquitination on the target, and its fate. The many possible paths by which ubiquitin may
be transferred from the E1 to the E2 to the E3 provides a great deal of specificity in
substrate ubiquitination and degradation, in addition to the other non-degradative
functions of ubiquitination.
1.2.3 Ubiquitin-like conjugation systems and ubiquitin-like proteins
In addition to ubiquitin-activating, enzyme, many eukaryotes possess other E1s
involved in activating a variety of other ubiquitin-like proteins such as SUMO and Nedd8
(Schulman & Harper, 2009).
1.3 Proteasome
The proteasome is a large, catalytic, multi-subunit protein complex present in
eukaryotic cells. It degrades proteins that are no longer needed due to changes in
7

environmental conditions, cell cycle stage, or development. Proteasomes are located
throughout the cytosol and often enriched within the nucleus, and comprise a dynamic
complex with many parts that can interchange depending on the needs of the cell.
The structure of the proteasome comprises a dynamic set of subunits that can be
remodeled and exchanged to adapt to varying cellular conditions. The most commonly
referred-to form is the 26S proteasome, which is composed of a 20S core particle (CP),
and a 19S “cap” or regulatory particle (RP). The RP and the CP each consist of multiple
polypeptides. A schematic diagram of the 26S proteasomal subunit composition is shown
in Figure 1.2, and an overview of its assembly is illustrated in Figure 1.1B. It functions
by proteolytically degrading polypeptides within the center cavities of the barrel-shaped
CP. Much of the degradative activity of the proteasome is enhanced and specified by the
RP, which recognizes proteins to be degraded, unfolds them, and drives them into the
central chambers of the CP in an ATP-dependent process. The primary degradation
products are short polypeptides, which are released to the cytosol and are further
degraded by other cytosolic proteases.
1.3.1 19S Regulatory Particle
The primary criterion by which the 19S regulatory particle recognizes condemned
proteins for degradation is the presence of polyubiquitin chains that are covalently
attached to lysine residues on the targeted substrate protein. A polyubiquitin chain that
contains at least 4 ubiquitins serially linked from the C-terminus of one ubiquitin
molecule to lysine 48 of the next ubiquitin molecule comprises the most common
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structure for recognition by the RP, while chains with linkages to other lysine molecules
within ubiquitin's amino acid sequence provide other types of functionality.

Figure 1.2: Schematic diagram of 26S proteasome structure

1.3.2 20S Core Particle
The core particle (CP), or 20S proteasome consists of 4 heptameric rings, stacked
to form a cylinder-like structure with several inner cavities. The two central rings each
consist of β subunits 1-7, three of which (β1, β2, and β5) are threonine proteases
responsible for the proteasome's three types of degradative activity: trypsin-like,
chymotrypsin-like, and peptidylglutamyl peptide hydrolyzing (PGPH, or caspase-like)
activity. The two outer rings that form the entrances to the “barrel” consist of α units 1-7.
9

The quaternary structure of eukaryotic proteasomes lacks radial symmetry, as subunits
within the α and β subunit categories are non-identical. However, the core particle shows
C2 symmetry about an axis orthogonal to the cylindrical axis, and is formed from two
identical α1-7-β1-7 half-proteasome complexes each containing two rings (Groll et al.,
1997; Tomko & Hochstrasser, 2013).
In some organisms, the three proteolytic β subunits can be replaced by IFN-γinducible subunits β2i, β3i, and β5i. The 20S CP can also form a complex with several
other large multi-protein subunits.
1.4 Functions and Cellular Dynamics of the Ubiquitin-Proteasome System
The ubiquitin-proteasome system (UPS) comprises the E1-E2-E3 series of
ubiquitination enzymes, the deubiquitinases, the 26S proteasome, and the biochemical
relationships between them. The total protein content of cell dedicated to the UPS is
estimated to be around 1.3% (Clague et al., 2015). In yeast, 1% of total yeast proteins
are proteasome subunits (Russell et al., 1999). A total of 90% of cellular proteolysis has
been shown to be dependent on ATP-dependent processes (Gronostajski et al., 1985).
Proteins that are modified by aberrant chemical reactions or otherwise misfolded
to due to high heat, mutations, etc. are typically recognized as abnormal by molecular
chaperones, which may attempt to re-fold them. Proteins that pass through this first line
of defense and are unable to be re-folded may be recognized by E3 ubiquitin ligases,
which then proceed to tag the misfolded protein with ubiquitin. Ubiquitin-mediated
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proteolysis is one of the terminal ends of cellular protein quality control, and degradation
products serve as a source of amino acids for synthesis of new proteins.
If the cell's protein quality control systems are overwhelmed, it may lead to an
accumulation of misfolded proteins. Numerous studies have shown that proteasome
inhibitors induce the formation of intracelluar protein aggregates, as misfolded proteins
often contain abnormally exposed hydrophobic patches, they are prone to forming
aggregates which vary in their capacity to be degraded or re-folded.
1.5 Caenorhabditis elegans
1.5.1 Introduction
Caenorhabditis elegans is a small soil nematode that is widely used as model
organism. Originally chosen by Sydney Brenner in the 1960's as a model organism for
the study of development, the worm was further characterized and developed as a model
throughout the 1970's and 1980's. Numerous breakthroughs in genetics, neurobiology,
embryology, development, and aging have been achieved using worm models.
C. elegans provided the first full genome sequence for a multicellular organism
(C. elegans Sequencing Consortium, 1998), the discovery of RNA interference (Fire et
al., 1998), and provided the first neurological “wiring diagram” (White et al., 1986) and
near-complete connectome (Varshney et al., 2011) of an organism's nervous system. In
addition, studies on worm lifespan led to key discoveries in the genetics of aging.
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1.5.2 Biological characteristics of C. elegans
1.5.2.1 Introduction
C. elegans are found in the soil of temperate zones worldwide. They are nonparasitic and free-living, feeding on bacteria that are primarily found near decaying
organic matter. Newly-hatched L1 larvae are less than 0.3 mm in size, while fully-grown
adults can reach approximately 1.2 mm. Adult hermaphrodites consist of 959 somatic
cells. As nematodes are eutelic, this number is fixed and genetically determined,
allowing the lineage of all cells to be mapped from fertilization. Somatic cells are
differentiated into nervous, muscular, excretory, and digestive systems. Most C. elegans
are hermaphroditic, producing zygotes from self-produced sperm and oocytes. After a
short period of cell division in utero and development of a protective shell, eggs are laid
outside the body (Riddle et al., 1997).
The C. elegans genome consists of 100 Mb of DNA on 5 autosomes and the X
chromosomes, encoding 20,267 protein-coding genes (“Wormbase,” 2016). Some
notable differences from most vertebrates include a lack of singular centromeres on
chromosomes, a smaller average intron size, a reliance on trans-splicing, and the presence
of operons.
1.5.2.2 Life history
After undergoing 9 hours of ex-utero development, C. elegans hatch from eggs,
progressing through four larval stages, designated L1-L4, molting between each stage
and again prior to reaching adulthood (Byerly et al., 1976).
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During starvation, overcrowding, and other stress, worms can exit the L2 stage
and become “dauer”, a longer-lived, stress-resistant, non-reproductive state marked by
decreased metabolism and locomotion, and a shrunken, elongated body with a thickened
protective cuticle. Upon detection of food or relief from stress, dauer larvae can resume
development by molting and entering the L4 stage (Cassada & Russell, 1975).
Reproduction in hermaphrodites begins approximately 12 hours after reaching
adulthood. Eggs are laid approximately 2 hours after self-fertilization occurs, reaching a
rate of about 9 eggs per hour at maximum for a total of 200-300 eggs per individual.
99.9% of self-fertilized zygotes develop into hermaphrodites, with males occuring after a
non-disjunction of the X chromosome occurs during meiosis. When males mate with
hermaphrodites, sperm from the males are favored in fertilization and contribute to a
higher total number of progeny (Hodgkin et al., 1979).
Hermaphrodites live for approximately 19 days at 21ºC (Byerly et al., 1976). As
worms enter senescence, egg-laying ends, and they show reduced locomotion.
Knockdown or mutagenesis of many genes have been shown to increase lifespan, with
most of these genes involved in environmental stress resistance pathways controlled by
the insulin-like signaling pathway and the HSF (heat shock factor) pathway (Hamilton et
al., 2005; Morley & Morimoto, 2004). While the nervous system remains largely intact
until near death, aging worms show significant muscle cell degeneration and
accumulation of oxidized proteins and pigment-containing granules in the gut. In
addition, there is a general increase in protein aggregation (David et al., 2010).
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1.5.3 Utility as a Model
As a model organism, C. elegans is easy to propagate in the laboratory. The short
life cycle makes the worm highly amenable to genetic manipulation, and crosses between
strains can be accomplished by using males. Typical culture conditions include
incubation at 16º, 20º, or 25ºC on petri plates containing agar medium and a lawn of E.
coli as a food source.
A recent bioinformatics study estimated as many 7,663 C. elegans genes have
human orthologs (Shaye & Greenwald, 2011). Gene expression in many tissues can be
knocked down by feeding bacteria that express short interfering RNA (siRNA). This
simple method of RNA interference allows for relatively easy reverse genetics, and two
major RNAi libraries are readily available: the Ahringer library and the Kamath library,
which cover approximately 87% of known C. elegans genes, are readily available (Qu et
al., 2011).
As the bodies of C. elegans are transparent, a variety of microscopic techniques
can be used with live animals to observe nearly any tissue. Fluorescence microscopy is
especially useful, as fusions of fluorescent proteins such as GFP to proteins of interest
can easily be tracked to better aid in understanding gene and protein function. C. elegans
are easily modified by transgenesis, by methods including microparticle bombardment
and microinjection.
The combination of optical visibility, genetic tractability, and well-characterized
genetic and developmental homology make C. elegans a useful platform for general
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biology and studies that are potentially translatable to mammalian physiology. Its small
size, rapid life cycle allow for rapid large-scale genetic or pharmacological screens.
1.5.4 Current rationale
Protocols for specific silencing of gene expression by RNAi have been well
established in our laboratory, and the current study builds on previous work using RNAi
in worms. Some of the earliest and best-characterized work with the C. elegans model
were focused on the musculature of the worm. Fluorescent fusions proteins are readily
visible in body wall muscle cells. In addition, many tissues and biochemical pathways
show similarity to vertebrates, including the UPS.
1.5.4.1 Ubiquitin-proteasome system in C. elegans
The ubiquitin-proteasome system is highly conserved from yeast to worms to
vertebrates. Ubiquitin in C. elegans is encoded by two genes. ubq-1 encodes a
polyubiquitin precursor that is cleaved to produce monomeric ubiquitin (Graham et al.,
1989), similar to the human UBC and UBB loci. ubq-2 encodes a fusion protein of
ubiquitin and the 60S ribosomal protein L40 that is also cleaved post-translationally
(Johnston et al., 1999), similar to the human UBA52 locus. The amino acid sequences for
Homo sapiens and C. elegans ubiquitin vary by only a single amino acid.
1.5.4.2 E1 ubiquitin-activating enzyme
There is a single confirmed ubiquitin-activating enzyme in C. elegans, uba-1
(Kulkarni & Smith, 2008), while humans possess two (Pelzer et al., 2007). RNAi of uba1 produces embryonic lethality, and a hypomorphic temperature-sensitive mutation
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results in reduced ubiquitin-protein conjugates and impaired reproduction and
development (Kulkarni & Smith, 2008).
1.5.4.3 E2 UBCs
Twenty ubiquitin-conjugating enzymes (UBCs) have been identified in C.
elegans, while humans possess at least 35 (Wenzel et al., 2011). C. elegans possesses at
least one UBC in 15 of the 17 known UBC gene families (Michelle et al., 2009), and
disruption of many of them by mutation or RNAi leads to a variety of phenotypes
including developmental impairment.
1.5.4.4 E3 ligases
C. elegans possesses 9 HECT-domain E3s, 4 U-box domain proteins, 15
monomeric RING finger proteins (Papaevgeniou & Chondrogianni, 2014). For cullinRING ligases (CRLs), C. elegans produces four cullin proteins. The F-box family
utilized in CUL-1-based CRLs is highly expanded in C. elegans to include over 500 Fbox genes, while humans have 68 (Shaye & Greenwald, 2011). The expanded F-box
genes are purported to target infectious pathogens (Thomas, 2006).
1.5.4.5 Proteasome
The proteasome α subunits are encoded by C. elegans genes pas-1 through pas-7,
and β subunits encoded by pbs-1 through pbs-7. In the 19S regulatory particle (RP) The
AAA+ ATPases of the proteasome base are encoded by genes rpt-1 through rpt-6, and the
non-ATPase subunits are encoded by rpn-1,2,3,5,6.1,7,8,9,10,11, and 12.
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DNA sequences for proteasome subunit genes show a high degree of similarity
between humans and C. elegans. An examination using BLAST (Davy et al., 2001)
revealed the largest E-value for α-type subunits to be 2e-63 (Corresponding to a 49%
identity) and 1e-33 (34 percent identity) for beta-type subunits. For 19S ATPase subunits
the largest E-values were 1e-171 (83% identity) for ATPases and 8e-20 (36% identity) for
non-ATPase subunits. RNAi knockdown of many of these genes produces a variety of
severe phenotypes including embryonic lethality, abnormal movement and body
morphology.
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CHAPTER 2

AGGREGATION AND UBIQUITINATION

2.1 Introduction
2.1.1 Conformational Diseases and Aggregation
2.1.1.1 Overview of Conformational Disease
A number of diseases involve protein misfolding and are known as proteostasis,
or “conformational” diseases due to their association with protein misfolding and
aggregation (Tuite & Melki, 2007). The most well-known of these are neurodegenerative
diseases and include Alzheimer’s, Parkinson’s, and Huntington’s disease. Other
conformational diseases include cystic fibrosis and the muscle-wasting disease inclusion
body myositis. The proteins underlying these diseases vary in sequence and structure,
and the exact cause of the aberrant folding cannot always be attributed to specific
mutations. However, these diseases are commonly characterized histologically by the
presence of insoluble intracellular protein aggregates. These aggregates generally contain
the misfolded species along with a variety of other proteins. One common hallmark of
aggregates in conformational diseases is the presence of ubiquitin (Kuzuhara et al., 1988;
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Leigh et al., 1988; Perry et al., 1987; Prayson & Cohen, 1997; Sieradzan et al., 1999).
While it is not entirely clear to what degree the ubiquitin within aggregates has been
conjugated to the misfolded protein itself, to other aggregating species, or is present as a
free monomer, its presence indicates a potential role for ubiquitin in the aggregation
process or in the cellular response to aggregation.
2.1.1.2 PolyQ Disease
Proteins containing pathogenic polyglutamine expansions, such as those observed
in Huntington’s disease, spinal bulbar muscular atrophy, and spinocerebellar ataxia are
particularly prone to aggregation and formation of ubiquitin-positive inclusions (Orr &
Zoghbi, 2007). In vivo and in vitro studies on the misfolding and aggregation of
polyglutamine proteins have suggested a model in which one or more soluble, metastable
polyglutamine monomers form a critical nucleus that is prone to oligomerization. An
autocatalytic feedback loop involving the misfolded monomers and oligomers promotes
the transition of more monomers to the aggregation-prone conformation, accelerating the
oligomer formation (Kar et al., 2011).
2.1.2 Role of Aggregates
There is ongoing debate regarding the toxicity of intracellular protein aggregates.
Some evidence suggests that the aggregates may sequester non-pathological cellular
proteins and may lead to loss-of-function phenotypes for these proteins (de Pril et al.,
2007; Preisinger et al., 1999). Proteins containing polyglutamine tracts are particularly
prone to co-aggregation with other polyglutamine proteins (Kazantsev et al., 1999). In
cell culture models, expression of protein aggregates can cause impairment of the
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ubiquitin-proteasome system (Bence et al., 2001; Jana et al., 2001). Later studies
supported a model where the early or intermediate forms of protein aggregates caused
proteasomal impairment, which was relieved by inclusion body formation (Bennett et al.,
2005; Mitra et al., 2009; Ortega et al., 2010). Still, other evidence suggests that the large
aggregates may be neutral or cytoprotective for the cell (Arrasate et al., 2004; Gong et al.,
2008; Lajoie & Snapp, 2010; Nagai et al., 2007; Saudou et al., 1998).
The formation of aggregates may aid the cell’s proteolytic mechanisms in ridding
the cell of the misfolded protein. Chen and associates found that some nuclear inclusions
co-localize with areas of proteasomal proteolysis (Chen et al., 2008). Localization of
proteasomal components to polyglutamine-containing aggregates has been shown to
require the signaling adapter p62/SQSTM1 (Paine et al., 2005). Cytosolic aggregates
may be subject to degradation by autophagy (Ravikumar et al., 2002) as well as by the
ubiquitin-proteasome system (Webb et al., 2003).
In some cases, it appears that the cell actively transports misfolded proteins into
juxtanuclear, pericentriolar, vimentin-caged inclusions termed “aggresomes”, a process
that requires ubiquitination (Chin et al., 2010). This may reflect an adaptation by cells
that serves to sequester damaged proteins to a single location, allowing for more efficient
degradation by autophagy. The transport to aggresomes along microtubules is facilitated
by K63-linked polyubiquitin chains. The signaling adapter p62/SQSTM1 may also be
involved in directing aggregates to non-proteasomal protein degradation by autophagy
(Bjorkoy et al., 2005). K63-polyubiquitinated proteins are transported by dyneindynactin complexes via the adapter histone deacetylase 6 (HDAC6) (Chin et al., 2010).
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Formation of aggresomes may be protective, as experiments in which formation of these
structures is inhibited results in increased cytotoxicity to cultured cells (Taylor et al.,
2003). In addition, aggresomes appear to protect cells expressing the Parkinson’s
disease-associated proteins α-synuclein and synphilin-1 (Tanaka et al., 2004).
Protein aggregation also appears to be associated with the normal aging process.
A recent study found that general protein insolubility increases with age in C. elegans
(David et al., 2010). In addition, protein aggregation may play an important role in the
immune system. Dendritic cell aggresome-like-induced structures (DALIS), which
contain ubiquitinated proteins, have been hypothesized to be involved in temporary
storage of antigens during maturation of dendritic cells (Canadien et al., 2005).
2.1.3 Purpose of Study
The development of animal, cell, and in vitro systems has provided useful tools
for studying protein aggregation. Morimoto et al., have developed a transgenic strain of
C. elegans (henceforth referred to as Q82) that expresses an aggregation-prone stretch of
82 glutamines fused to GFP (Q82::GFP) in the body wall muscle cells (Satyal et al.,
2000). The polyglutamine reporter protein aggregates into distinct puncta that recapitulate
many of the features of disease-associated aggregates, including insolubility (Satyal et al.,
2000), interactions with chaperones (Kim et al., 2002), and positive staining for ubiquitin
(Caldwell et al., 2003). In a previous RNAi screen, our lab demonstrated that RNAi
knockdown of specific UBCs affects the size, number, and ubiquitin immunoreactivity of
these aggregates in the Q82 strain (Howard et al., 2007). Specifically, RNAi of ubc-1,
ubc-13, and uev-1 resulted in significantly smaller aggregates that did not stain positively
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for ubiquitin or proteasome. RNAi of ubc-2 or ubc-22 resulted in larger aggregates that
were fewer in number. Similar effects were seen after RNAi of human homologs of these
genes in cultured HEK293 cells (Howard et al., 2007).
The current study expands upon those results by examining dynamics of
aggregate formation in vivo. Determining the temporal patterns of aggregate formation
may provides clues about biochemical and thermodynamic aspects of protein
aggregation, as well as aid in defining the cellular response to aggregation. Information
about the timing of various components of the UPS can provide answers about how and
why protein aggregates contain large amounts of these components, and inform
therapeutic strategies.. In our experiments, time-lapse fluorescence microscopy of
Q82::GFP reveals a biphasic nature to polyglutamine aggregation in C. elegans. Initial
formation of microscopically visible aggregates occurs rapidly and is largely unaffected
by knockdown of UBCs. RNAi of ubc-22 resulted in higher levels of initial fluorescence.
RNAi of ubc-13 impedes growth of aggregates during the secondary growth phase.
Furthermore, we examined the dynamics of aggregate ubiquitination by use of a
fluorescent mCherry::ubiquitin fusion protein and found that localization of this protein
to the Q82::GFP aggregates occurs after initial formation. To examine mobility of
proteins, FRAP (fluorescence recovery after photobleaching) was used, while FLIP
(fluorescence loss in photobleaching) was used to examine the degree to which proteins
were sequestered within aggregates.
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2.2 Methods
2.2.1 Worm strains and maintenance
The Q82::GFP strain was created previously as an integrated strain (Satyal et al.,
2000) and subsequently converted to integrated strain UA4 (Caldwell et al., 2003). The
LN139 strain harboring an integrated transgene expressing the mCherry::ubiquitin fusion
protein in muscle cells was created via microparticle bombardment with a plasmid
created using the multisite Gateway system (Invitrogen). Entry plasmids for the unc-54
promoter, the unc-54 3' UTR, and the destination vector, pCR319, were gifts from Chris
Ritchie. The entry plasmid with the mCherry::ubiquitin open reading frame was created
by fusing mCherry to the N-terminus of ubiquitin in the pDONR221 vector. The LN149
strain (Q82+Ub) was created by crossing the UA4 strain with LN139.
The temperature sensitive uba-1 strain (RV110) was obtained from Harold Smith
and carries the it129 allele of uba-1 (Kulkarni & Smith, 2008). Males of this strain were
crossed with the UA4 strain. A line showing 100% lethality at the non-permissive
temperature and stably expressing the Q82::GFP transgene in the body wall muscle cells
was propagated and used for the current study (LN150). Aggregates in the LN150 strain
do not begin forming in significant numbers until approximately 24 hours after egg
laying.
Worm strains were maintained according to standard methods (Brenner, 1974).
Briefly, worms were cultured on nematode growth medium with E. coli strain OP50 and
incubated at 20°C, 16°C, or 25°C with 50% humidity. Worms for experimentation were
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chunked repeatedly from a stock plate containing starved worms. E. coli strains OP50
and HT115 were obtained from the Caenorhabditis Genetics Center.
2.2.2 Nematode RNAi
RNAi feeding clones and procedures were previously described (Howard et al.,
2007). Petri plates containing 4.0 mL of NGM agar were supplemented with IPTG
(Isopropyl β-D-1-thiogalactopyranoside) and ampicillin to achieve concentrations of 1.0
mM and 0.1 mg/mL, respectively. Plates were seeded with 125 µL of overnight HT115
culture and allowed to dry until the bacterial culture medium. L2 larval worms were
transferred to RNAi plates and allowed to mature and lay eggs. L1 and L2 progeny were
used for time-lapse observations. For RNAi treatment of Q82+Ub worms in time course
experiments, NGM plates containing 0.5% lactose and 100 mg/mL ampicillin were used
to induce dsRNA production in HT115 bacteria.
2.2.3 Microscopy and Time-lapse Analysis
Worms were washed from RNAi plates using M9 buffer and gravity sedimented
for 5 minutes to collect adults in pellets. Supernatants containing early larvae were
pelleted by further gravity sedimentation (20 minutes) and washed 3X in M9 buffer to
remove bacteria. Larvae were collected in a 15 µL drop of M9 and transferred to the
center of a dried agarose pad on a glass microscope slide. Slides were mounted by
applying a thin ring of petroleum jelly and placing a #1 coverslip over the ring.
For time-lapse imaging, worms were illuminated continuously using a Nikon
E600 epifluorescence microscope equipped with a 100-watt mercury lamp. A Nikon 10X
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objective was used in conjunction with the 2X optivar (200X total magnification).
Neutral density filters (#16 and #8) were placed in the light path to reduce illumination
intensity by a factor of 128. Images were captured continuously (1 minute per exposure)
using a Qicam 1394 Cooled-CCD monochrome camera, set at a gain of 0.6. Image Pro
Plus 6.1 (Media Cybernetics) software was used to capture and process images.
Newly-formed aggregates were manually identified in the time-lapse imaging
series. The total pixel intensity (on a scale of 0 to 4095) was measured over time in
square regions of interest where aggregates appeared. Only singular, stationary
aggregates forming in L1 and L2 worms were analyzed. Worms were imaged for a total
of 240 minutes.
For time-lapse imaging of Q82::GFP in uba-1 mutants, worms were grown at the
permissive temperature, 16°C. When plates were enriched with laid eggs, larvae and
adult worms were washed from the plates, leaving only eggs. Plates with eggs were
shifted to the non-permissive 25°C temperature. After 24 hours, hatched larvae were
washed from plates and subjected to time-lapse microscopy as described above.
To observe secondary growth of preformed aggregates, the aggregates existing at
the beginning of the time-lapse observation period were measured over time. The “Track
Objects” feature in Image Pro Plus 6.1 was used to automatically find and measure the
sum pixel intensity of these objects. Aggregates overlapping in the Z axis or in close
proximity to other aggregates were omitted. Data presented in Figure 2.3 begins at 30
minutes after the start of the observation period.
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To measure mCherry::ubiquitin colocalization to Q82::GFP aggregates, 2 series of
images were taken at multiple Z-planes using a 40X lens, first for mCherry, then for GFP.
Z-stacks were pseudocolored and merged to form 48-bit color z-stacks. The line profile
measurement tool in Image Pro 6.1 was used to measure GFP and mCherry fluorescence
across the center diameter of Q82::GFP aggregates.
2.2.4 Photobleaching experiments
All photobleaching experiments were performed using a Zeiss LSM710 laser
scanning confocal system coupled to a Zeiss Axio Observer.Z1 equipped with a 40X
1.2NA water-immersion lens. LN149 worms were chunked (transferred in a small piece
of agar medium) from stock plates and incubated for 72-hours. L4-stage and adult
worms were mounted on slides in M9 containing 5 mg/mL tetramisole as described
previously for time-lapse analysis. For FRAP, aggregates of interest in adult worms were
viewed at a zoom level of 22.0, with a frame size of 51.8 µm2. Fluorescence was
bleached to approximately 50% of initial intensity in an area of interest, and allowed to
recover while imaging. Images were acquired every 100 ms using bidirectional scanning
with a 555 nm laser (for mCherry) or 488 nm laser (for GFP) set to 0.5% power. 100 prebleach images were acquired prior to bleaching. Bleaching was directed to an area near
the periphery of the Q82::GFP aggregates in a rectangular area of 0.79 µm2 using the 555
nm laser at 100% power for 3 iterations or the 488 nm laser at 100% power for 1
iteration. A second, non-bleached region measured within the same aggregate was used
to control for acquisition photobleaching. Mobile fraction (Mf) was calculated from
FRAP data using the equation Mf= (If-I1)/(I0-I1), where If is the final fluorescence intensity
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in the bleached region after recovery, I1 is the fluorescence intensity immediately after
bleaching, and I0 is the fluorescence intensity prior to bleaching.
For FLIP, worms were viewed at a zoom level of 8.0, with a frame size of 396.0
µm2. Images were acquired every 3 seconds using unidirectional scanning. After 6
prebleach images were acquired, repeated bleaching was directed at a square area of 0.81
µm2 every 7 seconds using a 555nm laser set to 100% and running for 10 iterations per
bleach. Separate experiments were performed in which bleaches were directed to regions
within the aggregate or the cytoplasm, and fluorescence measurements were collected for
non-bleached regions within both the aggregate and the cytoplasm. To control for
acquisition photobleaching, fluorescence was measured in separate cell that was not
subject to FLIP. Relative fluorescence intensity was calculated using the following
formula (It/Nt)/(I0/N0), where It is the mean fluorescence intensity in the region of interest
at a given time point, Nt is the fluorescence intensity at non-bleached control region at a
given time point, I0 is the initial (pre-bleach) mean fluorescence intensity in the region of
interest, and N0 is the initial mean fluorescence intensity in a non-bleached control
region.
2.2.5 Immunofluorescence
Gravid (egg-carrying) Q82::GFP worms were age synchronized by treating gravid
adults with hypochlorite solution to extract embryos. These progeny were allowed to
hatch on a standard NGM plate and grow for 72 hours. Adult worms were then washed
from the plates, washed 3X in M9 buffer, and once in distilled water. Concentrated
worms were placed on a polylysine-coated slide and frozen in liquid nitrogen. The
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coverslip was removed and worms were fixed on the slides using -20°C methanol for 20
minutes. After several washes in phosphate-buffered saline (PBS), slides were blocked
for 30 minutes using normal goat serum. Worms were then incubated for 2 hours with
the primary antibody (diluted 1:200) specific for K48 (Millipore clone Apu2) or K63linked (Millipore clone Apu3) polyubiquitin chains. The secondary antibody (diluted
1:200) was tetramethylrhodamine (TRITC)-conjugated goat anti-rabbit IgG (Jackson
ImmunoResearch). Worms were imaged using a 40X lens. Images were collected at
multiple Z-planes first for TRITC, then for Q82::GFP. Images were generated by
flattening Z-stacks into composite extended depth-of-field images, which were
pseudocolored and merged to view colocalization.
2.3 Results
2.3.1 Initial Q82::GFP aggregate formation occurs rapidly in L1 and L2-stage
worms
The transgenic Q82 strain of C. elegans expresses a fusion protein that consists of
82 glutamine residues fused to GFP, under control of the unc-54 promoter for expression
in the body wall muscle cells. Aggregates form throughout the animal’s development to
adulthood (Satyal et al., 2000). We have employed this model to examine the early
formation of aggregates, and the role of ubiquitination in this process. L1- and L2-stage
worms readily form distinct puncta of Q82::GFP that appear concurrently with the
disappearance of diffuse, putatively soluble fluorescent material. This process of initial
aggregate formation (defined here as the time taken for total fluorescence to increase
from 10% to 90% of maximum), takes an average of 58.1±21.5 minutes. Initial
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formation is represented by a sigmoidal curve (Figure 2.1) when plotted as a function of
time. This is followed by secondary growth, in which fluorescence increases at a slower
rate. Aggregates forming during time-lapse observation are similar in size to those that
were formed prior to microscopic observation, and show similar recovery after
photobleaching (Figure A.1).
In order to examine the potential role of ubiquitination in the aggregation process,
strain LN150 was created by crossing the Q82::GFP transgene into a strain harboring a
temperature-sensitive mutation in the uba-1 gene, which is the single gene encoding the
ubiquitin E1 activating enzyme in C. elegans. It has previously been shown via
immunoblots with anti-ubiquitin antibodies that overall ubiquitination is dramatically
reduced (>90% reduction of ubiquitin conjugates) under nonpermissive conditions (25ºC)
in this mutant (Kulkarni & Smith, 2008). Figure 2.1 shows the mean fractional intensity
(± SEM) of Q82::GFP fluorescence during aggregate formation in Q82 worms and strain
LN150, from a total of 58 aggregate formation events in 5 different time-lapse
experiments with the Q82 strain and 30 formations in 3 experiments with LN150. This
shows that in the time-lapse assay, under nonpermissive conditions, reduction of UBA-1
activity in LN150 does not change the kinetics of single aggregate formation events, as it
does not significantly affect the sigmoidal shape of the curve, the maximum rate of
formation, or the time taken for an aggregate to form. This result suggests that the
process of initial aggregate formation may not be directly dependent on ubiquitination.
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Figure 2.1: Aggregation profile of Q82::GFP fusion protein in C. elegans body wall
muscle cells with or without inhibition of ubiquitination.

2.3.2 RNAi knockdown of UBCs has limited effect on the initial aggregate growth
phase
We have previously shown that RNAi knockdown of specific UBCs can affect
the size and number of aggregates in worms at an age of 48 hours (Howard et al., 2007).
Specifically, the most dramatic phenotypes were seen with ubc-1, -2, -13, -22, and uev-1.
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Therefore, these UBCs were chosen for further analysis. For RNAi-mediated
knockdown, the identical RNAi feeding strains and protocols were used that have been
previously shown to reduce RNA levels (Howard et al., 2007). Time-lapse microscopy
was used to observe initial formation of Q82::GFP aggregates in UBC knock-down
worms, using the pL4440 empty vector as a control. RNAi treatment was started in L2
worms, and the L1 progeny of those worms were used for time-lapse imaging.
Fluorescence measurements of time-lapse image series were made by recording the total
intensity of all pixels over time in a square region framing the boundaries of the final
aggregate. After performing multiple experiments, aggregation data were pooled by
treatment group, aligned for the temporal coincidence of aggregate formation, averaged
at each time point, and values were plotted to form composite curves (Figure 2.2).
Notably, RNAi of ubc-22, and, to a lesser extent, uev-1, resulted in an increase in initial
levels of Q82::GFP, and an increase in the rate of initial aggregate formation. To
compare the effects of the RNAi treatments on the rate of aggregation, a linear regression
was performed on composite curves at the period of initial rapid aggregation (minutes 5862). These data are shown in Table 2.1. The table shows that almost all UBCs had an
effect on initial fluorescence levels. This may be due to a general disruption in the UPS
by disruption of key components in that pathway. ubc-13 was the only UBC to show no
significant effect on initial fluorescence level. Higher initial levels of Q82::GFP are
associated with higher rates of aggregation. This correlation suggests that once an
aggregate is initially seeded, its formation is largely diffusion-limited and dependent on
concentration, rather than active cellular pathways.
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Figure 2.2: RNAi knockdown of several UBCs affects the level and aggregation rate of
Q82::GFP fusion protein.
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Table 2.1: Initial fluorescence levels and aggregation rates of Q82::GFP fusion protein
RNAi treatment

Initial fluorescence
level prior to
aggregation (Sum pixel
intensity, ±SEM)

Aggregation rate of
initial formation
(change in pixel
intensity • minutes-1)

pL4440
(empty vector)

2712 ±452

208.1

ubc-1

3335 ±394

286.2

ubc-13

2827 ±347

177.9

ubc-22

9349 ±1124

344.9

uev-1

4847 ±450

255.8

2.3.3 RNAi knockdown of UBCs influences the secondary aggregate growth phase
In the C. elegans Q82 model, aggregates in adult worms are much larger than
those seen in young larvae. The data in figures 2.1 and 2.2 show that initially aggregates
form quickly, but that after initial formation, aggregates continue to grow at a slower rate.
Since RNAi of UBCs affects aggregate size, we investigated whether the UBCs might
affect this secondary growth phase. From the same population of worms in which we
observed aggregate formation, we recorded the growth of aggregates that had formed
prior to observation under the microscope (Figure 2.3). Table 2.2 summarizes the growth
rates of these aggregates, as determined by a linear regression performed on the data from
Figure 2.3. In this case initial fluorescence level indicates the level of fluorescence in the
existing aggregate at initial observation during the L1 larval period. Initial fluorescence
of aggregates was higher in worms subjected to RNAi of ubc-22, consistent with our
previous findings (Howard et al., 2007). In addition, ubc-22 and ubc-1 RNAi aggregates
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grew at rates faster than the control (Table 2.2). Aggregates in worms treated with ubc13 and uev-1 RNAi showed smaller aggregates, consistent with results from our previous
study (Howard et al., 2007). In addition, secondary growth was markedly reduced upon
RNAi of ubc-13 (Table 2.2). Since homologs of ubc-13 and uev-1 are known to dimerize
and to catalyze the formation of K63-linked polyubiquitin chains (Hoege et al., 2002;
Hofmann & Pickart, 1999), it is possible that the reduced secondary growth rate may be
related to reduced levels of K63 ubiquitination.
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Figure 2.3: RNAi knockdown of several UBCs alters the secondary growth of aggregates.
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Table 2.2: Initial fluorescence levels and growth rates of pre-formed aggregates
RNAi treatment

Initial fluorescence level

Growth rate of pre-formed
aggregates (change in pixel
intensity • minutes-1)

pL4440
(empty vector)

11761 ±1131

17.52

ubc-1

12224 ±1078

21.17

ubc-13

6781 ± 510

8.95

ubc-22

12546 ±1287

19.19

uev-1

9927 ±706

17.40

2.3.4 Aggregates of Q82::GFP contain both K48- and K63-linked polyubiquitin
chains
Q82::GFP aggregates in the Q82 strain stain positive for ubiquitin using a panubiquitin primary antibody, similar to intracellular aggregates in many diseases (Howard
et al., 2007). Since the linkage type of a polyubiquitin chain attached to a substrate is
important in determining that protein’s fate, examining the types of polyubiquitin chains
present in the aggregates may provide clues as to the role of ubiquitin in aggregate
formation. In an immunofluorescence assay using antibodies specific to K48- or K63linked polyubiquitin chains, we found that the Q82::GFP aggregates in adult worms stain
positive for both linkage types (Figure 2.4). Both large, spherical aggregates and the
smaller, more granular aggregates appear to contain both polyubiquitin chain types.
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Figure 2.4: Immunostaining of transgenic
adult C. elegans reveals localization of K48and K63-linked polyubiquitin chains to
Q82::GFP aggregates.

2.3.5 Higher levels of ubiquitin colocalization are seen in L4 stage worms
A C. elegans strain expressing mCherry::ubiquitin with Q82::GFP in muscle cells
(hereby referred to as Q82+Ub) was used to assess the dynamics of ubiquitin localization
to aggregates. A time course of mCherry::ubiquitin colocalization was performed, in
which worms were imaged every 12 hours and line profile fluorescence measurements
(Demonstrated in Figure 2.5A, showing a line of 10.16 µm, or 45 pixels) of individual
aggregates were taken to evaluate mCherry::ubiquitin colocalization to Q82::GFP
aggregates. Peaks represent fluorescence values in the aggregates while peripheral points
represent cytosolic fluorescence. Values are the mean (±SEM) of all values at that
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distance coordinate for aggregates at the given time point. Our results show a spike in
mCherry::ubiquitin colocalization in aggregates at 36 hours (Figure 2.5C, D). In the
same experiment, groups exposed to RNAi of ubc-1 or ubc-22 show reduced
colocalization of mCherry::ubiquitin to the polyglutamine aggregates (Figure 2.5D) at 36
hours.
The results indicate that ubiquitin localization to polyglutamine aggregates varies
with developmental stage. This finding is consistent with other reports suggesting that
the protein quality control pathways are not constant throughout all periods of the life
cycle. Interestingly, the ratio of mCherry to GFP fluorescence seems to decrease from 36
hours to 48 hours (Figure 2.5D). As Q82::GFP aggregates increase in size during this
time, the decrease in mCherry::ubiquitin colocalization may be the result of the activity
of deubiquitinating enzymes (DUBs).
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Figure 2.5: An mCherry::ubiquitin fusion protein shows increased colocalization to
Q82::GFP aggregates at an age of 36 hours which is diminished by RNAi of ubc-1 or
ubc-22.
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2.3.6 Photobleaching experiments reveal mobility of mCherry::ubiquitin within
Q82::GFP aggregates.
Ubiquitin within aggregates may be attached to the primary aggregating protein,
attached to other proteins that coaggregate, or associated as a free monomer. The
mobility of the protein may provide insights into its conjugation state. FRAP and FLIP
experiments were performed in order to examine the mobility of mCherry::ubiquitin
within aggregates of Q82::GFP. In the FRAP experiments, mCherry or GFP was
bleached within a region of the Q82::GFP aggregates in adult worms and fluorescence
recovery was observed (Figure 2.6A, B). Fluorescence intensity was pseudocolored in
figures 2.6A, B and 2.7A, B, with intensity increasing from blue to red. Q82::GFP
showed a slight recovery (Figure 2.6C) with a mobile fraction of 23.3% ± 9.2. The
mCherry::ubiquitin fusion protein showed a higher degree of recovery, with a mobile
fraction of 70.8% ± 17.0. This result indicates that while the polyglutamine protein,
Q82::GFP, is highly immobile within aggregates, ubiquitin shows a greater rate of
diffusion. The slow, continued increase in mCherry recovery after the initial rapid
recovery may indicate the continued accumulation into aggregates of mCherry::ubiquitin
or substrates to which it is attached.
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Figure 2.6: FRAP analysis of mCherry::ubiquitin and Q82::GFP in polyglutamine
aggregates reveals differential mobility of ubiquitin and polyglutamine proteins within
aggregates.
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Figure 2.7: FLIP analysis of mCherry::ubiquitin and Q82::GFP in body wall muscle cells.
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To further investigate the mobility of mCherry::ubiquitin within Q82::GFP
aggregates, FLIP (Fluorescence Loss In Photobleaching) was used. mCherry was
continuously bleached in a region either within the Q82::GFP aggregate or in the
cytoplasm of a cell expressing the two fusion proteins. Loss of fluorescence in either a
separate region within the aggregate or in the cytoplasm was monitored to examine
mobility of the fluorescence material (Figure 2.7A, B). Red squares indicate bleach
regions, black and white squares indicate analysis regions, and yellow squares indicate
control regions in neighboring cells. Bleaching target regions of either the cytoplasm or
the aggregate itself did not result in loss of fluorescence within the non-targeted region of
the aggregate, indicating mCherry::ubiquitin is sequestered within aggregates. Bleaching
within the cytoplasm reduced cytoplasmic mCherry fluorescence, indicating the
effectiveness of the bleaching protocol and the mobility of mCherry::ubiquitin within the
cytoplasm (Figure 2.7C). The FLIP and FRAP results combined support the notion that
the mCherry::ubiquitin is sequestered within the Q82::GFP aggregates, but is not itself in
an aggregated, immobile configuration.
2.4 Discussion
The presence of ubiquitin within protein aggregates is a common feature in
multiple diseases. Many of these diseases are age-related and may be associated with
impairment of protein quality control. Thus, it is important to investigate the role that the
ubiquitination machinery plays in the process of aggregation. In this study we examined
the early formation of intracellular polyglutamine aggregates, and did not find a direct
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role for ubiquitin-conjugating enzymes in initial aggregation, but that they are likely
responsible for ubiquitinating substrates that are recruited to aggregates later.
2.4.1 Initial Q82::GFP aggregation occurs rapidly and is not directly dependent on
ubiquitination
Initial formation of Q82::GFP aggregates in C. elegans muscle cells completes in
approximately 1 hour. This is a rapid process, when considered in the context of the
slow, age-associated onset of many polyglutamine diseases. Aggregation rate was
correlated with levels of Q82::GFP immediately prior to aggregate formation. A
dependence of aggregation rate on concentration is consistent with a model in which the
initial aggregation is a spontaneous, entropy-driven process that is dependent on
biophysical parameters such as temperature, concentration, and diffusion coefficient.
Interestingly, the aggregation curves for Q82::GFP resemble a sigmoidal curve, which is
suggestive of a model of nucleation followed by autocatalytic growth. Indeed, in vitro
aggregation experiments in systems lacking ubiquitination machinery produced
aggregation curves that fit a sigmoidal curve (Morris et al., 2008). It should be noted that
the standard fluorescence microscopy techniques used in this study are unable to detect
the formation of smaller, subresolution Q82::GFP oligomers and protofibrils. Such
smaller species may be forming during the “lag time” prior to rapid aggregation, as seen
in vitro (Lee et al., 2007).
The observation that formation time does not change significantly in worms in
which ubiquitination has been impaired due to a temperature-sensitive mutation in uba-1
further suggests that ubiquitination is not required for initial aggregation in this model.
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In support of this model, only very low levels of mCherry::ubiquitin are seen colocalizing
to Q82::GFP aggregates in young worms, the age in which aggregates begin appearing
(within 24 hours of hatching). Similar results are seen in the ubiquitination of the
Parkinson’s Disease protein α-synuclein. In transfected cells, mutant α-synuclein that
cannot be ubiquitinated can still form aggregates, though the propensity for aggregation
increases when it is mono- or di-ubiquitinated (Lee et al., 2008). In a mouse model of
Huntington's disease, immunohistochemistry revealed similar results: rapid (< 1 day)
appearance of aggregates preceding positive staining of aggregates for ubiquitin (Gong et
al., 2012).
A higher level of initial fluorescence is seen after RNAi of ubc-22 and is
associated with a higher rate of aggregation, both in the initial formation and the
secondary growth phases. A higher level of Q82::GFP fluorescence may indicate a
higher concentration of the fusion protein in the area where the aggregate forms. Thus, it
is possible that UBC-22 normally functions in the degradation pathway of Q82::GFP.
Eliminating its function may allow Q82::GFP to accumulate, resulting in larger
aggregates formed from the increased quantity of intracellular protein. E2-25K, the
human homolog that is most closely related to UBC-22 (32% identity), has been shown
to be involved in the formation of K48-linked polyubiquitin chains (Chen & Pickart,
1990) and to interact with the polyglutamine-containing protein huntingtin (Kalchman et
al., 1996). Since K48 chains are associated with proteasomal degradation, this UBC may
be involved in targeting aggregating proteins for degradation.
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The role of UBC-22 may be in localized or spatially restricted degradation of
Q82:GFP, since levels of GFP fluorescence levels measured in whole worms did not
show differences between control and ubc-22 RNAi. Thus, UBC-22 may have some role
in preventing the accumulation of Q82::GFP in specific compartments of the cell.
Alternatively, UBC-22 may play a role in setting the threshold for initial aggregation. As
cytosolic levels of Q82::GFP increase, molecular crowding can decrease the quality of
the protein folding environment and increase the probability of polyglutamine proteins
adopting an aggregation-prone conformation. Depletion of UBC-22 by RNAi may
increase the threshold concentration of Q82::GFP at which aggregates appear, via
mechanisms yet to be elucidated. One possible explanation is that UBC-22 normally
regulates chaperone activity in C. elegans, either indirectly by downregulating qualitycontrol pathways such as the heat-shock response, or directly by labeling a chaperone for
destruction by the proteasome.
UBC-22 is an atypical UBC in that the cysteine residue (C74) near the putative
catalytic domain is positioned 12 residues N-terminal to its expected position. This
positioning brings into question whether this UBC is truly catalytically active. UBC-22
also appears to lack some residues critical in binding ubiquitin in the UBC domain. In
Ubc1, the yeast ortholog of UBC-22, docking analysis shows that residues L89-I91 and
N119-P121 interact with ubiquitin when the C-terminus of ubiquitin is placed at the
active site cysteine residue of Ubc1 (Hamilton et al., 2001). UBC-22 lacks corresponding
residues. The same analysis also revealed several residues (E117, D120, and A111) in
Ubc1 that appear to form hydrogen bonds with ubiquitin. UBC-22 has closely
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corresponding residues (E101 and D110) for E117 and D120, but, unlike E2-25K, lacks a
residue corresponding to A111. Interestingly, a yeast two-hybrid analysis showed that
UBC-22 interacts with the RING finger E3 ligase NHL-1 (Gudgen et al., 2004). Further
experiments exploring the interaction of UBC-22 and NHL-1 and their effects on
aggregation may provide insight into the role of UBC-22.
2.4.2 Ubiquitin conjugating enzymes may affect aggregation during the secondary
growth phase
After the initial aggregation phase, polyglutamine aggregates continue to grow in
a slower, secondary growth phase. This secondary rate of growth is reduced by RNAi of
ubc-13 and to a lesser extent, uev-1. UBC-13 and UEV-1 have been shown to interact in
a yeast two-hybrid experiment (Kramer et al., 2010), S. Utarrala and L.B., (unpublished
data) and therefore may function as a dimer. In yeast, the orthologs of this dimer is
capable of catalyzing the formation of K63-linked polyubiquitin chains. Since our
current study shows that K63-linked chains are present at polyglutamine aggregates, it is
possible UBCs associated with K63 ubiquitination may promote the secondary growth of
polyglutamine protein aggregates. This mechanism may also explain the apparent
disparity between the relative sizes at the end of the initial aggregate formation
(Figure 2.2), and the beginning of the observation of mature aggregates (Figure 2.3). As
initial formation was observed largely in L1 and L2 animals, and mature aggregates
observed in Figure 2.3 were largely found in L2 and L3 animals, the secondary growth
rates during the intervening period can account for the observed differences. Specifically,
ubc-1 worms exhibit the highest secondary growth rate (Table 2.2) and these aggregates
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become comparable in size to the initially larger ubc-22 aggregates over time. Also, ubc13 worms show the slowest secondary growth rate (Table 2.2) and they then represent the
smallest aggregate population observed in the mature aggregate population (Figure 2.3).
We propose reduced K63-linked ubiquitination as a possible explanation for the lack of
growth seen in ubc-13, and, to a lesser extent, uev-1 RNAi-treated animals.
In other systems, it has been proposed that K63 ubiquitination of aggregating
proteins leads to trafficking of oligomers to aggregation sites (Olzmann et al., 2007). It is
unknown if this same scenario exists in the C. elegans muscle. In mammals, the adapter
protein p62 has been implicated in this trafficking process (Paine et al., 2005). p62
contains a UBA domain that is capable of binding to K63-linked polyubiquitinated
proteins, and has been shown to promote aggregation in vivo and in vitro. C. elegans
possesses a protein, SEPA-1, which, like p62, can recruit specific proteins to the
autophagy machinery for degradation. However, it is unknown if SEPA-1 can bind
polyubiquitin chains (Zhang et al., 2009). An alternative hypothesis is that K63-linked
polyubiquitin chains may compete with K48-linked chains for binding to the proteasome
(Hofmann & Pickart, 2001). It is possible that the reduction of K63-linked
polyubiquitination in the cell might allow for increased degradation of K48-linked
polyubiquitinated proteins thus depleting the cell of aggregation-prone proteins and lead
to smaller aggregates.
mCherry::ubiquitin localization to aggregates is highest in the early L4 larval
stage. This agrees with a time course where major ubiquitination events occur after
initial aggregate formation. This accumulation of ubiquitinated proteins may be related
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to general changes in protein homeostasis that occur in C. elegans aging (Ben-Zvi et al.,
2009). Alternatively, the late localization of ubiquitin to the aggregates could be the
result of increased proteasome inhibition caused by protein aggregates. The results of our
study agree with observations by Stenoien, et al. using a cotransfection assay of polyQexpanded ataxin fused to cyan fluorescent protein (CFP) and yellow fluorescent protein
fused to ubiquitin. They reported that small aggregates of CFP-ataxin-84Q were typically
not ubiquitinated, while many larger aggregates contained high levels of ubiquitin
(Stenoien et al., 2002). Treating the co-transfected cells with the proteasome inhibitor
MG132 resulted in accumulation of YFP-ubiquitin into aggregates. In addition, there is
some histological evidence to suggest that ubiquitination of aggregates follows their
formation. Studies using huntingtin or ubiquitin-specific antibodies to examine the brains
from individuals suffering from varying clinical grades of HD found that ubiquitin was
not present in all aggregates, and was present in a higher percentage of aggregates in
higher clinical grades of the disease (Gutekunst et al., 1999). Animal studies found that
in a mouse model of the polyglutamine expansion disease SCA7, the appearance of
ubiquitin-positive aggregates occurred no earlier than 12 weeks of age, which is up to 7
weeks later than the earliest detection of aggregates in certain tissue (Yoo et al., 2003).
2.4.3 Ubiquitin is mobile but sequestered within Q82::GFP aggregates
In this study, both K48 and K63 ubiquitin chains were detected in Q82::GFP
aggregates. Similar to many previous reports, we observed that the antibody staining is
strongest in the periphery of the aggregates. The peripheral staining has prompted the
question of whether that pattern was a result of ubiquitin being restricted to the periphery
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or whether the antibodies might be unable to penetrate into the interior of the aggregate.
In the Q82+Ub strain, many aggregates also show higher mCherry fluorescence in the
periphery (Figures 2.4A, D and 2.5B), supporting the idea that ubiquitin is at a higher
concentration at the peripheral regions of the aggregate. A tempting explanation for this
is that ubiquitination is occuring on aggregates after initial formation.
The FRAP results are also consistent with later deposition of ubiquitinated
proteins. These results, like previous FRAP studies of aggregated fluorescent fusion
proteins (David et al., 2010; Kim et al., 2002; Roberti et al., 2011), show that there is
little to no mobility of the aggregating species. Some aggregate associated proteins are
seen to be mobile or transiently associated with aggregates, including chaperones (Kim et
al., 2002), CBP, proteasome subunits (Stenoien et al., 2002). Similarly, the
mCherry::ubiquitin protein is largely mobile. The differences in mobility between
Q82::GFP and mCherry::ubiquitin indicate that a detectable fraction of ubiquitin is not
conjugated onto the polyglutamine protein. It may be brought to aggregates via
association with other proteins or it may exist in aggregates as a ubiquitin monomer.
Differences in the conjugation state of the mCherry::Ub may also explain the biphasic
nature of the FRAP curve for this protein. The rapid, initial recovery may be due to free
mCherry::Ub diffusing into the measurement area, while the slower, secondary recovery
may be occurring as ubiquitin chains or larger ubiquitinated proteins diffuse into this
space. Alternatively, different topologies of mono- or polyubiquitin moieties may have
different binding modes with respect to ubiquitin receptors sequestered within the
aggregate, thus providing varying diffusion kinetics within this environment.
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Interestingly, examination of the Q82::GFP aggregates using FLIP shows that
mCherry::ubiquitin within the aggregates does not exchange significantly with the
cytoplasm. This sequestration of ubiquitin into aggregates may indicate a high
concentration of ubiquitin receptors within the aggregate. In accordance with this, cell
based assays using polyQ-expanded ataxin found that aggregates of this protein contain
ubiquitin binding structures including PUB motifs, ubiquitin-interacting motifs (UIMs),
and ubiquitin-associated (UBA) domains (Donaldson et al., 2003). Ubiquitinated
proteins may be recruited to aggregates via binding to these domains. Of course, this
prompts the question of how these ubiquitin binding proteins are recruited to aggregates.
The proteasome, which contains both chaperone-like subunits and ubiquitin binding
domains (Kim et al., 2011), may be the source of ubiquitin attracting activity in
aggregates. Proteasomes may initially localize to aggregates via affinity for misfolded,
ubiquitinated proteins. If proteasomes become engaged in failed attempts to unfold and
degrade polyglutamine fibrils, this may lead to the accumulation of ubiquitinated
substrates in the cytoplasm. Finally, accumulation of proteasomes at aggregates may
explain the secondary accumulation of ubiquitin to the aggregates in our model. In
support of this, our previous RNAi screen indicated that RNAi treatments that
significantly reduce the size of aggregates also eliminated ubiquitin immunoreactivity in
the aggregates, and RNAi of ubiquitin itself resulted in smaller Q82::GFP aggregates
(Howard et al., 2007). Another possible explanation for the seemingly different
mobilities seen between the FRAP and FLIP studies of the mCherry::Ub protein within
the aggregate is that the aggregates have subcompartments or are formed from multiple
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smaller aggregates. If this is the case, then it could be expected that bleaching an area of
the aggregate will result in a quick recovery of fluorescence in the bleach area (as in the
FRAP results), without reducing fluorescence in a separate part of the aggregate by
exchanging mobile protein.
2.5 Conclusion
These studies provide insight into the role of ubiquitination in a nematode
model of polyglutamine protein aggregation. Time-lapse analyses of aggregate formation
indicate an initial phase of growth that is likely spontaneous and not directly dependent
upon ubiquitin. RNAi of ubc-22 affects the initial aggregation rate by increasing
intracellular levels of soluble Q82::GFP fusion protein. Secondary growth is slower and
appears to be more affected by ubiquitination. There is a period during the fourth larval
stage in which ubiquitin is maximally located to Q82::GFP aggregates. Ubiquitin appears
to be mobile, but sequestered within aggregates. These results suggest a model in which
polyglutamine proteins misfold and rapidly form small aggregates, which subsequently
attract substrates that have been ubiquitinated by a variety of E2 and E3 enzymes. The
development of therapies for protein-misfolding disorders may benefit from further
understanding of how ubiquitination is involved in the handling of misfolded, damaged,
or aggregating proteins.
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CHAPTER 3

PROTEASOME LOCALIZATION IN ADULT C. ELEGANS

3.1 Introduction
3.1.1 Overview
Proteasomes are distributed throughout the nucleus and cytosol of eukaryotic
cells, and are able to diffuse freely within these compartments as they perform classic
proteolytic functions of the ubiquitin-proteasome system. A body of evidence has
revealed, however, that the subcellular localization of the proteasome can be regulated to
fit the needs of different cell types or aid in responding to varying cellular states or stress
conditions. Further adaptation is possible as the proteasome itself has a variable and
dynamic structure, with a variety of alternative and regulatory subunits interacting with
and incorporating into the holoenzyme for long-lived or transient time periods. The bulk
of this knowledge has been obtained using yeast and cell lines, or in
immunohistochemical and proteomic studies of mammals. The present study in C.
elegans allows for convenient imaging of proteasomes in live animals, providing a
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context that takes into account differentiated tissues and organism-wide regulation of
responses to varying conditions.
3.1.2 Proteasome Localization
3.1.2.1 Overview
Proteasomes localize to a variety of organelles and other cellular structures. It is
well established that proteasomes reside within the nucleus, as they have been observed
in yeast (Russell et al., 1999; Saeki et al., 2009; Wendler et al., 2004), rat hepatocytes
(Brooks et al., 2000), Arabidopsis (Yao et al., 2012), and Allium epidermal cells
(Choudhary et al., 2009). Other work in yeast has shown proteasomes localized to the
nuclear envelope, (Enenkel et al., 1998; Sha et al., 2007; Yen, Espiritu, et al., 2003).
Localization to the nuclear envelope has also been seen in rat hepatocytes (Brooks et al.,
2000) and the tobacco-derived cell line BY-2 (Samuel et al., 2009).
The cytoplasm contains the other major reservoir of proteasomes, seen in yeast
(Laporte et al., 2008; Saunier et al., 2013), human fibrosarcoma cells (Reits et al., 1997),
Arabidopsis (Yao et al., 2012), and protozoans (Muralidharan et al., 2011).
Proteasomes are occasionally found extracellularly. In vertebrates, proteolytically
active 20S proteasomes (c-proteasomes) are found circulating in the serum. Levels of cproteasomes correlate with inflammation and are elevated in certain cancers (LavabreBertrand et al., 2001; Wada et al., 1993) and in certain autoimmune diseases (Egerer et
al., 2002). They are also found in the alveolar fluid, where they may be involved in
regulation of oncotic pressure (Sixt et al., 2007).
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Broadly, proteasomal degradation can serve three purposes: elimination of
damaged or abnormal proteins, elimination of obsolete proteins, and the recycling of
amino acids for the synthesis of new proteins.
3.1.3 Spatial Dynamics of Proteasomes
Presumably, proteasomes diffuse passively to meet polyubiquitinated proteins
destined for degradation. However, proteasomes can be enriched within certain cellular
compartments, either by regulated transmembrane transport of various subunits, regulated
assembly, or tethering and sequestration mediated by interacting proteins.
Early work on proteasome dynamics showed rapid diffusion of fluorescentlylabeled proteasome subunits within the nuclei of human fibrosarcoma cells.
Photobleaching a small area of the nucleus greatly reduced fluorescence in the entire
compartment in as little as 10 seconds, even after depletion of ATP. Cytoplasmic
proteasomes showed similar behavior. Thus, a large fraction of proteasomes are rapidly
mobile as they diffuse within the cytoplasm and nucleoplasm (Reits et al., 1997).
Proteasome mobility within the nucleus of yeast is dependent on the actin regulatory
protein Arc3 and the actin cytoskeleton (Cabrera et al., 2010). This Arc3-dependent
mobility is required for phleomycin- and UV-induced DNA damage repair.
3.1.3.1 Nuclear functions of proteasomes
Proteasomes are known to fulfill a variety of functions in the nucleus.
Proteasomal degradation can regulate transcription in varied and complex ways,
including degradation of RNA polymerase II subunits (Beaudenon et al., 1999), and
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destruction of transcription factors and related proteins (Salceda & Caro, 1997; Wu et al.,
2007). Genome-wide chromatin immunoprecipitation study in Saccharomyces showed
that most yeast genes are associated with proteasome subunits (Sikder et al., 2006),
indicating a key role for proteasomes in regulating transcription.
Cytosolic proteasome substrates are often imported into the nucleus for
degradation. Interestingly, some misfolded cytosolic proteins maybe transported into the
nucleus prior to ubiquitination and degradation (Prasad et al., 2010), illustrating that the
accumulation of proteasomes in the nucleus may allow it to be an important compartment
for protein quality control.
3.1.3.2 Location-Specific Functions
The traditional model of proteasomal degradation describes ubiquitinated
substrates as diffusing through cytosol until they collide with subunits of the proteasome
that recognize the polyubiquitin conjugate, leading to the degradation of the substrate.
This may occur directly by interaction with bona fide proteasome subunits, or via adapter
proteins that bind both polyubiquitinated substrates and proteasome-bound ubiquitin
receptors. Multiple lines of research have indicated that spatial compartmentalization of
proteasome function may play a role in controlling cellular function and maintaining
proper protein folding states. A localized increase in proteasome concentration can
increase the effective rate of the degradation reaction, as well as increase the specificity
of target substrate selection.
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In neurons, proteasomes retained at the synapse are involved in degradation of
receptors for rapid remodeling of neuronal signaling (Bingol & Schuman, 2006). In
yeast, proteasomes are often localized to the nucleus, but have been found to accumulate
in cytoplasmic granules during quiescence, which may serve to store them for rapid
mobilization upon re-entering the cell cycle (Laporte et al., 2008). Furthermore,
proteasomes may concentrate in specific substructures to mediate the degradation of
misfolded proteins, such as the aggresome (Ben-Gedalya et al., 2011), clastosome
(Lafarga et al., 2002) and other centers of protein aggregation.

3.1.3.3 Localization Mechanisms
Cellular localization of proteasomes may be achieved in any of several ways, and
vary depending on cell type. The aforementioned study using fibrosarcoma cells showed
rapid movement of GFP-labeled proteasome that was ATP-independent, indicating a
passive mode of transport. These cells also demonstrated unidirectional transport of
proteasomes from the cytoplasm to the nucleus. (Reits et al., 1997). In another study,
several lines of evidence suggested that the adapter protein Ecm29 acts to link the 26S
proteasome and molecular motors (Gorbea et al., 2010). Such a transport method maybe
more effective than diffusion for relocalizing proteasomes across longer distances, as in
axons. In fission yeast, repression of Arc3, which regulates the actin cytoskeleton,
inhibits the transport of proteasomes into the nucleus, making them hypersensitive to
DNA damage (Cabrera et al., 2010). Furthermore, repression of Arc3 reduces mobility
within the nucleoplasm.
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The localization of proteasomes to various compartments is tightly linked to its
proper assembly. One mechanism of proteasome localization to the nucleus in yeast is
import of subunits in a way that is dependent on the lid subunit Rpn5 (Yen, Gordon, et
al., 2003). The proteasomal affinity for the nucleus in yeast may be mediated by a tether
protein, Cut8, which is absent in humans (Takeda et al., 2011, p. 8). Recently, Nmyristoylation of 19S subunit Rpt2 in yeast has been shown to maintain nuclear
localization of proteasomes (Kimura et al., 2016).
3.1.3.4 Cell specialization
The degradative activity of proteasomes has been adapted for tissue-specific
functions. In the remodeling of synapses that is required for synaptic plasticity,
proteasomes are sequestered into the dendritic spines of neurons to facilitate localized
protein degradation. This sequestration was affected by electrical activity and may be
mediated by interactions with the actin cytoskeleton. Interestingly, this concentration of
proteasomes was associated with a concomitant concentration of polyribosomes (Bingol
& Schuman, 2006).
In sperm, proteasomes are concentrated with other UPS components in the
cytoplasmic droplet (“Hermes body”) and are involved in cell development, particularly
sperm motility (Au et al., 2015). It has been proposed that 20S proteasomal complexes
remain at the ER to refine the size of peptides to be presented on MHC Class I molecules
(Yang et al., 1995). Proteasomes may be involved in HIV restriction, as proteasome
subunits have been seen associating with TRIM5alpha complexes in HeLa cells
expressing fluorescently-labeled HIV-1 virions (Lukic et al., 2011).
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3.1.4 Muscles
Muscles present a unique role for protein degradation, as they possess large,
mechanical stress-bearing protein structures and, for many vertebrates, serve as a store of
amino acids that can be mobilized following proteolysis.
The contractile functions of myocytes (muscle cells) are performed by myofibrils,
which are bundles of overlapping protein filaments that exert sliding force against one
another. They include actin, which form thin filaments, and are attached to the z-line.
Mechanical force is transmitted from the cell via z-discs (termed dense bodies in C.
elegans) on the z-line. The thick filament, formed primarily from myosin, is anchored to
the M-line. The force is generated by the ATP-driven contraction of the “head” domain
of myosin against the actin filament, which causes the two filaments to slide past one
another. Myofibrils are arrayed in contractile units called sarcomeres, which consume a
large volume of the myocyte (Au, 2004; Geeves & Holmes, 1999). The precise
arrangement of proteins in muscle cells requires elaborate quality control in order to
maintain efficient locomotive ability in the face of growth, aging, and stress. Figure 3.1
shows the arrangement of body wall muscle cells in C. elegans and the ultrastructure of
the sarcomere.

59

Figure 3.1: Body wall muscles of adult C. elegans.
A) Overview of worm anatomy with dorsal muscle quadrants. B) Cross-section of worm
showing muscle quadrants. C) Detail showing arrangement of cells within quadrant. D)
Top view of muscle cell. E) Cross-section of muscle cell, showing the contractile
apparatus and muscle belly. F) Sarcomere structure showing thin filaments (grey) and
thick filaments (red).
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3.1.4.1 Age-related muscle pathologies
The etiology of movement disorders, particularly in the elderly, is of great clinical
interest. Sarcopenia is a progressive, degenerative wasting of muscles that is highly
prevalent in the elderly (Sakuma & Yamaguchi, 2012). The general role of the ubiquitinproteasome system in muscle protein degradation has been examined in the context of
aging and age-related disease. There is some evidence that sarcopenic muscles have
enhanced ubiquitin-proteasome activity (Altun et al., 2010), while other studies show that
it is reduced (Ferrington et al., 2005; Husom et al., 2004). Thus, the precise roles which
the UPS plays in sarcopenia remains unclear. Cachexia, a wasting condition associated
with pathological muscle wasting, occurs in patients suffering from a variety of diseases.
Often the muscle wasting may not be directly associated with malnutrition or lack of
activity, but by incompletely understood pathways that signal muscles to break down
protein via various proteolytic mechanisms (Sakuma & Yamaguchi, 2012).
Sporadic inclusion-body myositis (s-IBM), a common muscle pathology in the
elderly, is characterized in part by accumulation of aggregated protein. Proteasomes have
been shown to be inhibited in s-IBM, and proteasome components are found within
aggregates in s-IBM muscles (Fratta et al., 2005). Thus, proteasomal impairment could
play a causative role in s-IBM.
3.1.4.2 Muscle Proteasome Localization
Proteasomes in muscle generally show patterns of subcellular localization similar
to other cell types. Early immunohistochemical work, prior to detailed characterization
of the proteasome itself, identified a “multi-catalytic protease” localized in the nucleus of
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cultured rat skeletal muscle cells (Stauber et al., 1987), while a similar study using a
different antibody localized “ingensin” (later identified as proteasome) to the cytoplasm
of skeletal muscle (Kamakura et al., 1988). Another immunohistochemical study with
crab claw and hamster abdominal muscle also showed cytoplasmic staining, but with
dense aggregates at the cell membrane that did not appear at the nuclei or mitochondria.
There was some indication that proteasome was localized between myofibrils.
Immunoprecipitation indicated proteasome in microsomes and the cytosol (Beyette &
Mykles, 1992).
A study (Kumamoto et al., 2000) comparing proteasome immunohistochemical
staining of normal vs. dystrophic human muscles showed weak cytosolic staining in
normal muscles but increased staining in the cytoplasm of necrotic and regenerative
fibers. Staining was weak in the sarcoplasm.
Immunofluorescence studies with antibodies against several 20S subunits
examined “prosome” localization in the soleus muscle of adult rats and in cultured
cardiomyocytes (Foucrier et al., 2001). In many cases they observed bands that ran
perpendicular to the axis of the muscle fiber. This likely correlates with sarcomere, as
smooth muscles, which lack sarcomeres, do not show this ultrastructural sarcomeric
banding pattern. However, some banding is seen in smooth muscles, which may indicate
arrangement of prosomes with cytoskeletal elements.
In rat muscle cells, proteasomes have been found to be associated with myofibrils
(Bassaglia et al., 2005), likely through an unidentified binding partner. A study using
immunogold labeling in developing insect muscles found proteasomes on
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heterochromatic regions in nuclei, but not myofibrils or cytoplasm. However, when these
cells underwent programmed cell death, proteasomes were found to relocalize to
myofibrils and various degraded portions of the cytosol (Low et al., 2000).
Other components of the UPS are involved in critical muscle functions. Several
ubiquitin ligase enzymes (E3s) have been identified that ubiquitinate muscle-related
proteins, further illustrating the role for the proteasome in muscle function. Muscle
RING-finger 1 (MuRF1), a ubiquitin ligase responsible for recognizing and
ubiquitinating specific muscle proteins, has been associated with muscle atrophy.
Specifically, it has been shown to degrade proteins that stabilize the myosin heavy chain
(Cohen et al., 2009). In C. elegans, UNC-45 is chaperone that is critical for formation of
thick filaments. It is known to be ubiquitinated by the ubiquitin ligase UFD-2-CHN-1
complex after myofilament assembly, though some UNC-45 can remain associated with
myosin heavy chain B into adulthood and may function to stabilize the myofilament (Ao
& Pilgrim, 2000). The precise sequence of events leading to ubiquitination and
degradation of UNC-45 is unclear, though it is critical for proper muscle function.
While C. elegans does not carry a gene with sequence similarity human Aβ, a
major component of s-IBM aggregates, general protein aggregation has been shown to
occur in aging wild-type C. elegans muscles (David et al., 2010; Reis-Rodrigues et al.,
2012). In particular, David et al. identified multiple proteasome subunits as becoming
insoluble with age.
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3.1.5 Purpose of Study
Given the limited animal data available on proteasome localization in vivo,
particularly in muscles, we sought to observe proteasomes in live animals using
fluorescence microscopy. The body wall muscle cells of C. elegans are particularly
amenable to this type of analysis due to their size and location in this transparent animal,
and fusions of proteasome subunits to fluorescent proteins have previously been shown to
incorporate into functional proteasomes in multiple cell types. To this end, we
constructed a transgene that encodes the proteasome subunit RPT-1 fused to green
fluorescent protein (GFP) and used it to create a strain of worms that expresses this gene
within body wall muscle cells. Using this model, we examined proteasome localization
in body wall muscle cells in adults at three different ages, as well as localized
proteasomal activity using a fluorescent reporter.
3.2 Methods
3.2.1 Creation of Expression Construct
To produce expression constructs for transgenes, multi-site Gateway cloning was
performed. The Gateway(R) cloning system utilizes the sequence-specific recombination
sites of bacteriophage lambda (att sites) to easily transfer DNA from a variety of sources
to and between many different vectors. The pCFJ150 plasmid contains MosSCI
recombination sites flanking the wild-type unc-119 rescue allele and two Gateway attB
recombination sites. During the LR reaction, four recombination events occur: A 5’
construct containing the promoter of interest and a 3’ construct containing the ORF for
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Citrine, mCherry, or GFP both recombine with a middle fragment from a construct
containing the ORF of interest (C. elegans rpt-1). This new tripartite fragment
recombines with sites on a desination vector plasmid. Thus, four plasmids (the pCFJ150
destination vector and the three plasmids containing the desired transgenic DNA)
recombine simultaneously to create the expression plasmid (Zeiser et al., 2011).
Constructs with varying fluorescent proteins were used to increase the chances of
producing a strain with sufficient expression levels for microscopy. Figure 3.3 shows a
schematic of the transgene present in plasmid pGS1.
3.2.1.1 LR Reactions
LR reactions were generally performed as described in the manufacturer’s
manual. Reaction volumes were 10 μL total and contained 10 femtomoles of each entry
clone and 20 femtomoles of destination vector. Purified plasmids were combined with
TE buffer to achieve 8 μL volume. 2.0 μL of LR Clonase II Plus was added to each
reaction for a total reaction volume of 10 μL. After briefly vortexing, reactions were
incubated at 25°C for 16 hours. Proteinase K supplied with the kit was then added (1.0
μL per reaction) and incubated for 10 minutes at 37°C.
In this procedure, 2 reactions were run in attempts to produce expression
constructs for RPT-1::GFP, and RPT-1::Citrine.
The products of these reactions were used to transform competent DH5α E. coli
cells. 40 μL of thawed cell mixture was aliquoted into 1.5 mL microcentrifuge tubes, and
1.0 μL of reaction product was added its own tube. After mixing plasmid and cells in
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tubes, the mixture was transferred to a chilled cuvette and pulsed once at 1.4 kV with a
BTX Transporator Plus electroporator. 1.0 mL of SOC medium was added immediately,
and samples were incubated for 1 hour at 37°C with shaking then plated on TSA-amp
(tryptic soy agar with 100 μg/mL ampicillin) plates. One colony each was produced from
the RPT-1::GFP and RPT-1::Citrine reactions.
3.2.2 Purification of pGS1 plasmids
Plasmids were purified using Qiagen miniprep kit. Briefly, cultures were grown
overnight at 37°C with shaking using colonies of transformed bacteria grown on TSAamp plates and subjected to the Qiagen miniprep procedure listed in the manufacturer’s
manual, with the following changes: 3.0 mL total culture was used per sample. The lysis
step was allowed to continue for 5 minutes, and the elution proceeded for 2 minutes with
elution buffer heated to 37°C prior to elution at 37°C.
3.2.3 Injections for transgenesis
To create C. elegans strain GS1, which expresses RPT-1::GFP from
extrachromosomal arrays, EG6699 worms were injected with the pGS1 plasmid, at a
concentration of 101.8 ng/μL. Table 3.1 lists the plasmids and associated strains that
were used in all proteasome studies. After injection, worms were allowed to recover, and
were placed on standard Nematode Growth Medium (NGM) and placed at 25°C for
incubation.
The C. elegans strain EG6699 carries the ed3 mutation of unc-119, to facilitate
selection of successful transformants. The ed3 allele causes an uncoordinated movement
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phenotype in worms. For the purposes of propagation, this strain also carries an
extrachromosomal array encoding a rescue allele for unc-119 to allow normal movement.
This array is lost at a low frequency, providing animals that can be used for transgenesis.
For injections, non-rescued worms showing the unc phenotype are individually picked
onto agarose-padded coverslips in mineral oil. This coverslip is then placed on an
inverted microscope equipped with a needle prepared from a pulled capillary tube that
has been loaded with the DNA to be injected.
Briefly, EG6699 worms were picked from NGM plates and placed in heavy
mineral oil resting on a coverslip with a pad of dried agarose. Oil-immobilized worms
were injected pneumatically using a pulled needle guided by micromanipulator on a
Nikon TE-2000 inverted microscope. Following injections, worms were allowed to
recover in M9 for 1 hour. Worms were singled to NGM plates, allowed to reproduce, and
examined for rescued (non-unc) progeny.
Table 3.1: Strains and plasmids used for proteasome localization studies
Plasmid Worm Fluorescent Fusion Purpose
strain
expressed
EG6699
Transgenesis
pGS1-2C GS1

RPT-1::GFP

pGS2
GS2
pGS3 2-1 GS3

RPT-1::Citrine
GFP*

Reference
(Frøkjær-Jensen et
al., 2012)
This study

Proteasome localization
experiments
Alternative to GFP fusion This study
Control for proteasome
This study
localization experiments
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3.2.4 Generation of GFP control by deletion of RPT-1 ORF from pGS1 plasmids
To generate a control plasmid, the Stratagene QuikChange Lightning kit was used
to delete the RPT-1 ORF from pGS1. Forward primer GSDEL1-F (5'GTACAAAAAAGCATTCTTGTACAAAG-3') and reverse primer GSDEL1-R sequence
(5'-CTTTGTACAAGAATGCTTTTTTGTAC-3') were synthesized by MWG Eurofins
Operon (Huntsville, AL) and reconstituted to a 1 mM solution prior to use in
mutagenesis. The mutagenesis reaction was run using plasmid pGS1-518 as the template.
The resulting plasmid, pGS3a, was verified using restriction digest (Figure 3.2) in which
plasmid isolates were digested with the enzymes HindIII and EcoRI at a concentration of
1 unit/uL for 6 hours at 37ºC, then subjected to gel electrophoresis in a 2% agarose gel
for 35 minutes at 100V and stained with ethidium bromide for visualization of predicted
DNA fragment sizes under UV light. Fluorescent bands representing the predicted 5920,
2373, 1926, and 348 base pair bands were observed, while 90, 71, and 20 bp bands were
indiscernible. Lanes M1 and M2 in Figure 3.2 represent molecular size markers at 1000
base pair intervals. Sanger sequencing was used to further confirm plasmids.
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Figure 3.2: Agarose gel electrophoresis of pGS3 plasmid isolates
digested with HindIII and EcoRI.

3.2.5 Verification of plasmids by sequencing
Plasmids were verified for correct recombination by Sanger sequencing
performed by MWG Eurofins Operon (Huntsville, AL). The nucleic acid sequence of the
sequencing primers are as follows: PR1: 5'-TTCGCTGTCCTGTCACACTCG-3'. PR2:
5'-TGCCGCACACAGCTTTAC-3'. PR3 5'-AGAAGAAAGGTGGCAACTG-3'. PR4:
5'-CATCTGAGTGAAGTGAATGC-3'. Sequencing was focused on recombination sites
in order to verify the LR reaction. Region 1 covers the attB4 site, region 2 covers the
attB1 site, region 3 covers the attB2 site, and region 4 covers the attB3 site.
Two isolates of pGS1 were sequenced: four reactions for the pGS1-518 isolate,
and four reactions for the pGS1-2C isolate. All reactions for pGS1 were sequenced with
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primers PR1, PR2, PR3, and PR4. Four isolates of pGS3 were sequenced: 1 reaction for
each pGS3-2-1, pGS3-11, pGS3-14, and pGS3-15-1. pGS3 plasmid was sequenced with
primer PR2 only. Samples were submitted at 125 ng/L.
Sequences were verified using MegAlign software. Sequencing reads were
loaded into MegAlign concurrently with the predicted sequence that was previously
generated by predicting the recombination product in ApE, and aligned using the Clustal
V alignment. For pGS1-518, the reads in the four regions covering the attB4, attB1,
attB2 and attB3 sites matched the predicted recombined sequence, with matched residues
extending into flanking sequences. The one mismatch was located in the attB2 site,
where the base immediately 5' to the att site was predicted to be a T, but was read as a C.
For pGS1-2C, attB4, attB1, and attB3 sites matched the predicted sequence. For pGS3,
the region 2 reads were aligned in Megalign with the region 2 primer (Primer R2).
3.2.6 Microscopy and Time-course Observations
Worms were incubated at 16°C according to standard methods, as described in
section 2.2.1. Synchronized cultures of worms were obtained by incubating plates of fed
worms until the agar surface contained a sufficient number of eggs. All hatched worms
were washed from the plates and discarded. Eggs were then allowed to hatch for 2 hours
at 16°C. Newly-hatched worms were then washed from the plate, collected in a 1.5 mL
microcentrifuge tube, concentrated by gravity sedimentation, then transferred to new
OP50-seeded NGM plates. These synchronized worms were then incubated to the
desired time-points of 65 hours (young adults), 123 hours (egg-laying adults), or 240
hours (older adults) and observed with confocal microscopy for proteasome localization.
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Worms were anesthetized and mounted on agarose-padded slides as previously
described in section 2.2.3. Microscopy was performed using a Zeiss LSM700 laserscanning confocal system coupled to a Zeiss Axio Observer.Z1 light microscope. A 20X
lens was used to find and record the position of multiple RPT-1::GFP-expressing cells in
multiple worms. A 63X oil immersion lens was used to capture stacks of laser-scanned
images of cells with both reflected (for fluorescence) and transmitted (for DIC) light.
GFP was excited using the 488 nm laser at a power from 3% to 6%, depending on
fluorescent protein levels. Photomultiplier tube gain was manually adjusted to eliminate
sensor saturation from the cell of interest, typically using the nucleus as a target.
For phenotype scoring, z-stack images of fluorescent cells were loaded in Zeiss
Zen (2.1) software and analyzed by viewing image slices at multiple Z-depths and by
viewing 3D projections created from the Z-stacks. Numbers of foci were counted per
nucleus, and a “yes” or “no” was recorded for each phenotype if present or not. Results
were tabulated in Microsoft Excel 2010.
3.2.7 FLIP Studies
For FLIP, worms were mounted in M9 with tetramisole on agarose-padded
microscope slides as describe above. Experiments were performed on a Zeiss LSM700
laser-scanning confocal system coupled to a Zeiss Axio Observer.Z1 equipped with a 63X
oil immersion lens. The field of view was focused on the nucleus of a body wall muscle
cell expressing RPT-1::GFP. Regions of interest (ROIs) were selected within the Zeiss
Zen software for as many of the following regions as possible: bleach region, the distal
region of nucleoplasm, perinuclear cytoplasm, a “nuclear dot”, the nucleolus, the muscle
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arm, and two control regions (in neighboring cells). For image acquisition, a frame size
of 808 x 808 pixels representing 72.5 µm x 72.5 µm was selected. 3 pre-bleach images
were acquired, then the bleach region was bleached every 10 seconds with 100% laser
power and a pixel dwell of 4 µsec. Full-frame images were acquired immediately before
and after each bleach, using the 488 nm laser at a power of 2.0% for the control GFP
strain (GS3) and 5.0% for the RPT-1::GFP strain (GS1), at a pixel dwell of 0.81 µsec.
For each trial, a single worm was imaged for approximately 10 minutes. Data were
collected from several worms for each slide.
3.2.8 Hoechst Staining
For examination of nuclei in live worms, C. elegans strains were incubated at
16°C to an age of 96 hours, washed from NGM plates, then incubated in a staining
solution with 0.1 mg/mL Hoechst dye 33258 with 2% DMSO for 1 hour in a shaker at
room temperature. Worms were then washed 3X to remove bacteria and mounted for
microscopy. Hoechst dye was excited using a 405 nm laser, and GFP or RPT-1::GFP was
excited using a 488 nm laser.
3.2.9 Proteasome substrate staining
Proteolysis within live worms was visualized with MeOSuc-Phe-Leu-Phe-AFC
(MP Biomedicals, Santa Ana, CA). This compound consists of a tripeptide (Phe-LeuPhe) conjugated to 7-amino-4-trifluoromethylcoumarin (AFC) by an amido bond. The
AFC becomes fluorescent after cleavage of this bond by proteases and subsequent release
from the tripeptide, with an emission spectrum peaking at 505 nm.
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To localize proteasomal activity within live C. elegans body wall muscle cells,
worms were soaked in M9 medium containing 200 µM of the fluorogenic substrate and
0.5% DMSO (dimethylsulfoxide) for 2.5 hours, then mounted as described in section
2.2.3. For confocal fluorescence microscopy, fluorescent cleaved substrate was excited
using the 405 nm laser.
3.2.10 Proteasome Immunofluorescence
Worms to be stained were washed from NGM plates, washed 3X in M9 and 1X in
deionized water. Worms were transferred to polylysine slides (slides coated by spreading
polylysine over slides and allowing to dry, repeating 2X for a total of 3 coatings) in
approximately 10 μL of diH2O. Worms were subjected to the “Freeze-crack” method of
permeabilization. A coverslip was placed over the worms and the slide was placed in
liquid nitrogen for 20 minutes. After removing slides from nitrogen and prying the
coverslip off with a scalpel, slides were placed in -20°C methanol for 20 minutes to fix
worms, then washed 3X in phosphate-buffered saline containing 0.5% tween (PBST) for
5 minutes. Slides were blocked for 30 minutes with 30% normal goat serum in PBST.
Blocking solution was removed, and slides were incubated with primary antibody (rabbit
polyclonal anti-human proteasome subunit 10B) diluted 1:100 in 30% NGS in PBST.
Slides were washed again 3X in PBST then incubated with secondary antibody
(goat anti-rabbit-TRITC) diluted 1:200 in 30% NGS in PBST at 4°C. Slides washed 3X
in PBST. Excess fluid was removed, then 5 μL Vectashield with DAPI was added. A
coverslip was placed over the worms and sealed to the coverslip around the edges with
nail polish remover and allowed to set for 15 minutes at room temperature.
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3.3 Results
3.3.1 Creation of strain
Worms expressing RPT-1::GFP or GFP from extrachromosomal arrays were used
for all experiments. Strain GS1 expresses RPT-1::GFP, and strain GS3 expresses GFP
(produced by deleting the RPT-1 ORF from pGS1 and injecting EG6699 worms with the
resultant pGS3 plasmid). Figure 3.3 shows the structure of the transgene for pGS1
assembled with the 3-fragment gateway recombination. It consists of the C. elegans unc54 promoter upstream of the ATG start codon, with the ORF from C. elegans rpt-1, a
flexible linker region, and the GFP ORF downstream of the start codon. The 5’ UTR
(untranslated region) from tbb-1 is present after the stop codon to aid in expression.

Figure 3.3: Schematic of rpt-1::gfp transgene, showing attB recombination sites, unc-54
promoter, ORFs, and 5’ UTR.

Strain GS1 possesses 55% heritability of the transgene (as detected by normal
movement phenotype due to unc-119 rescue) after self-fertilization. RPT-1::GFP
expression is visible in body wall muscle cells and some neurons. However, individual
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animals are chimeric, with many cells displaying no fluorescence. This provides an
internal negative control for fluorescence and allows easy characterization of individual
cells.
For a fluorescent fusion protein to accurately represent the subcellular localization
of a multi-subunit complex, it must be stably integrated into that complex. Fluorescent
fusions with proteasome subunits, including fusions with RPT-1 and its yeast homolog,
have previously been shown to incorporate into functional proteasomes with high
efficiency (Bingol & Schuman, 2006; Enenkel et al., 1998). Fluorescence recovery after
photobleaching (FRAP) has been shown to be a useful tool for investigating succesful
incorporation of RPT-1::GFP into mult-subunit complexes (Groothuis & Reits, 2005).
A representative FRAP trial for strains GS1 and GS3 is shown in Figure 3.4.
Regions of bleached RPT-1::GFP recover slowly and incompletely, while regions of the
control GFP recover rapidly, indicating rapid mobility. This result indicates that the RPT1::GFP may be properly incorporated into the proteasomal holoenzyme. FLIP
(Fluorescence Loss in Photobleaching) experiments were performed in which a small
region in the nucleus is bleached, and multiple regions in the nucleus and cytoplasm are
examined for loss of fluorescence. Micrographs from a representative FLIP result is
shown in supplemental results, Figure A.5, and are quantified and summarized in Figures
A.6-A.9. Results from FLIP indicated that RPT-1::GFP is not rapidly exchanged between
the nucleus and cytoplasm as GFP is.
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Figure 3.4: Single FRAP trial of RPT-1::GFP shows low mobility of RPT-1::GFP protein
relative to GFP control.
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3.3.2 Proteasome Localization in Adult worms
Adult worms of strain GS1, expressing RPT-1::GFP were raised at 16°C and
examined at various ages. Young adults (65 hours post-hatching), egg-laying adults (123
hours post-hatching), and older adults (240 hours post-hatching) were collected and body
wall muscle cells that showed fluorescence were examined using confocal microscopy.
Figure 3.5 shows detail of a representative muscle cell in a worm of age 123 hours
expressing either RPT-1::GFP (Panels A, E, I, M) or control GFP (Panels C, G, K, O) at
various depths, with matching differential interference contrast (DIC) images. The
images in Figure 3.5 are representative of cells in 34 GS1 worms and 28 GS3 worms
from 3 different experiments. Both RPT-1::GFP (A, E, I, M) and GFP (C, G, K, O)
appear largely localized to the cytosol or nucleoplasm and excluded from many
organelles. RPT-1::GFP in the contractile apparatus appears to be localized to the I-band
region (containing thin filaments only) but excluded from dense bodies, while GFP
appears to localize to both I-bands and A-bands (which contain both thin and thick
filaments). In the muscle belly (I-L, M-P), both RPT-1::GFP and GFP appear to be
concentrated in the cytosol and somewhat excluded from organelles. Both RPT-1::GFP
and, to a lesser extent, GFP appear to be concentrated in the nucleoplasm and excluded
from the nucleolus.
Cells were systematically scored and the frequency of occurrence of various RPT1::GFP localization phenotypes for worms of various ages were quantified and are shown
in Table 3.4 for the contractile apparatus and Table 3.2 for the nucleus. The nucleolus
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shape and degree of cellular vacuolation were categorized qualitatively and counted and
are shown in Figures A.2 and A.3 in Appendix A.

Figure 3.5: Localization of RPT-1::GFP and GFP in muscle cells of egg-laying adults
incubated at 16°C at various depths within a muscle cell.
Scale bar in panel A represents 5 µm. Each row represents progressively deeper sections
of the body wall muscle cell, beginning with the contractile apparatus and dense bodies at
0 µm depth, extending down 2.3 µm to the muscle belly and nucleus.

78

3.3.2.1 RPT-1::GFP localization in the nucleus and cytosol
In general, RPT-1::GFP in muscle cells is enriched in the nucleus relative to
cytosol, but excluded from the nucleolus. It is present diffusely throughout the cytosol,
but somewhat excluded from various organelles (Figure 3.5, panels I, M). Control GFP
shows similar cytosolic distribution but nuclear levels are similar to cytosol (Figure 3.5,
panels K, O).
In many nuclei, RPT-1::GFP forms at least one punctate, intensely fluorescent
focus, while control GFP never forms foci (Figure 3.6A). Table 3.3 shows the number of
nuclei containing various numbers of foci. The number of foci per nucleus drops during
the egg-laying period, while it is higher in young and older adults. Nearly half of nuclei
in young and older adults contain at least 1 focus, while in the egg-laying stage, the vast
majority of nuclei contain no foci. As worms age, RPT-1::GFP in the nucleus is more
likely to be found concentrated not only in foci but also in mottled regions of
concentrated fluorescence, rather than diffusely present in the nucleoplasm (Table 3.2).
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Table 3.2: Occurence of nuclear RPT-1::GFP phenotypes in RPT-1::GFP-expressing adult
C. elegans.
Animal age

RPT-1::GFP
enriched in
nucleus

Young Adults

Nuclei
Mottled RPT-1::GFP Diffuse RPTContaining Foci in nucleus
1::GFP in nucleus

95.8%, n=24 41.7%, n=24

20.8%, n=24

95.8%, n=24

Reproductive Adults

100.0%, n=34 18.2%, n=33

56.7%, n=30

94.1%, n=34

Older Adults

100.0%, n=14 57.1%, n=14

57.1%, n=14

57.1%, n=14

Table 3.3: Number of nuclei containing various quantities of RPT-1::GFP foci

Binning
0 foci
1 focus
2 foci
3-4 foci
5-8 foci
9-16 foci
More than 16 foci
Total Nuclei
Observed:
Mean number of
foci per nucleus

Young
adults
13
6
16
3
4
6
2

Egglaying
adults
46
1
4
2
1
0
0

Older
Adults
5
6
4
2
2
1
0

50

54

20

3.7

0.4

2.0

To more closely examine RPT-1::GFP in nuclei, adult GS1 worms were stained
with Hoechst 33342 dye and imaged using confocal microscopy with a 100X lens.
Hoechst bis-benzimidazole dyes bind to the minor groove of DNA, particularly AT-rich
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regions. Areas of highly-compacted heterochromatin can be identified with Hoechst
staining. RPT-1::GFP is consistently excluded from regions that stain positive for
Hoechst (Figure 3.6, top row), while in the control GS3 strain (bottom row), GFP is
excluded to a lesser degree. Images in Figure 3.6 are representative of 7 RPT-1::GFP
worms and 6 GFP control worms that were observed.

Figure 3.6: Confocal microscopy of nuclei shows exclusion of diffuse and punctate RPT1::GFP from hoechst-stained regions and the nucleolus.
Scale bar in panel A represents 5 µm.

3.3.2.2 Adult Contractile Apparatus RPT-1::GFP
Within the contractile apparatus, RPT-1::GFP fluorescence is localized to I-bands
and is excluded from dense bodies often in egg-laying and older adults (Figures 3.5A,
3.7), while in the control strain, GFP is present in both I-bands and A-bands (Figure
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3.5C). Figure 3.7 shows an overview of RPT-1::GFP in the contractile apparatus, with
panels D, E, and F showing exclusion from dense bodies in the I-bands. This figure is
representative of 34 GS1 worms and 28 GS3 worms from 3 different experiments. Ibands are regions of sarcomeres containing the end regions of actin filaments and their
attachment to dense bodies, while A-bands are regions of overlapping actin and myosin
filaments. In some worms, RPT-1::GFP localizes continuously to I-bands and dense
bodies, forming long, interrupted lines. In some cells, RPT-1::GFP can be seen faintly at
M-lines, which are attachment points for myosin filaments. Dense bodies exclude RPT1::GFP in nearly 50% of observations.

Figure 3.7: Confocal fluorescence microscopy shows localization of RPT-1::GFP to the
contractile apparatus of body wall muscle cells in adult C. elegans.
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Table 3.4: Frequency of Contractile Apparatus RPT-1::GFP Phenotypes in adult C.
elegans.
Animal
age

Young
Adults

Exclusion of Localization Colocalization
RPT-1::GFP to I-bands of RPT-1::GFP
from dense
in dense bodies
bodies
0.0%, n=24

Solid Lines of RPT-1::GFP

58.3%, n=24

12.5%, n=24

37.5%, n=24

Reproducti 46.9%, n=32
ve Adults

85.3%, n=34

18.8%, n=32

69.7%, n=33

Older
Adults

85.7%, n=14

7.1%, n=14

78.6%, n=14

42.9%, n=14

3.3.3 Cleaved proteasome substrate forms a striated pattern
To localize proteasomal activity, worms were exposed to the synthetic proteasome
substrate MeOSuc-Phe-Leu-Phe-AFC and the fluorescent cleavage product was imaged
in body wall muscle cells using confocal microscopy. Cells showed longitudinal
striations of fluorescence that follow the I-bands of sarcomeres (Figure 3.8). This figure
is representative of 6 cells observed in 5 worms from this experiment.
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Figure 3.8: Proteasome substrate fluorescence shows a striated pattern in C. elegans
muscle cell contractile apparatus.

3.4 Discussion
The fluorescent RPT-1::GFP proteasome subunit fusion localized to the nucleus
and cytoplasm of body wall muscle cells in C. elegans, consistent with previous reports
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in multiple model organisms and cell types. The presence of diffuse, mobile fluorescence
in the nucleoplasm and cytoplasm supports a model of freely-diffusing proteasomes that
do not rapidly exchange between cellular compartments.
3.4.1 Cytoplasmic Localization
RPT-1::GFP shows fluorescence throughout much of the cytoplasm and is rapidly
mobile. There appears to be organelle-like areas of exclusion, which may be the ER or
nuclear envelope, which have previously been observed excluding fluorescent
proteasome fusions (Reits et al., 1997). Some cytoplasmic patterns of RPT-1::GFP
resemble previously reported images of mitchondria within body wall muscle cells. The
ubiquitin-proteasome system does regulate protein quality control for some mitchondrial
proteins, but this occurs within the cytosol (Bragoszewski et al., 2013), and mitochondria
contain their own ATP-dependent proteolytic system.
3.4.2 Contractile Apparatus
The localization of RPT-1::GFP fluorescence to I-band regions of sarcomeres with
exclusion from dense bodies supports a model of freely diffusing proteasomes, as the Iband regions, which contain only thin filaments, are less dense than the A-band regions of
the sarcomere. It is unlikely that many intact 26S proteasomes penetrate deep into the
contractile apparatus, particularly the A-band regions which consist of interdigitated thick
and thin filaments. The structure of the bovine 20S proteasome CP indicated a size of 15
nm in length and 10 nm in diameter (Unno et al., 2002), with similar size observed for T.
acidophilum (Löwe et al., 1995). The distance between rat thin and thick filaments in Abands ranges from 15-20 nm (Riley et al., 2005), and the ends of the thick filaments in C.
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elegans are about 15 nm in diameter at the ends of the A-bands, near the A-I junction. In
the C. elegans A-band, each thick filament is surrounded by 10-12 thin filaments
(Waterston et al., 1980). Given that myosin in thick filaments forms cross-links with thin
filaments as part of the contraction cycle, there is little available volume for a large
complex such as the proteasome to diffuse in at the A-band. Furthermore, the opening to
the CP inner chamber is at most 1.5 nm in diameter, far too small to allow in situ
degradation of contractile filament subunits. Accordingly, we observed the greatest
concentration of proteasomeal substrate in the I-bands, and it was rarely detected in other
parts of the sarcomere. This localization pattern matched that of the fluorogenic
proteasome substrate.
In mammalian muscle, the Z-band (the location of Z-discs) has been shown to
have a dense mesh of interconnecting filaments (Suzuki et al., 1976). If similar
interconnections exist in C. elegans, it could account for the exclusion of diffusing
proteasomes from the dense bodies (the nematode analog of z-discs). In some cases,
particularly young adults, dense bodies were difficult to discern in micrographs, and
exclusion from these structures was not always observed.
The dense, complex organization of protein protein fibers within the contractile
apparatus presents a special problem for the quality control of myofibrillar proteins such
as myosin, actin, and the accessory proteins that support them. Individual subunits that
become misfolded or damaged may not be as accessible to proteolytic components such
as the proteasome as would a soluble, globular protein in the cytosol. Accordingly,
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previous studies have shown that proteins assembled in myofibrils are resistant to
ubiquitin-mediated proteolysis (Solomon & Goldberg, 1996).
Proteins in need of repair may be shuttled by chaperones or removed from an
intact sarcomere by smaller proteases such as calpains (Neti et al., 2009). Myosin has
been shown to be degraded by UPS in conditions where the myosin chaperone UNC-45 is
inhibited (Landsverk et al., 2007). Our results here are in agreement with the idea that
sarcomeric proteins are not fully degraded in situ, but rather, released from myofilaments
by smaller proteases, which diffuse to meet proteasomes.
3.4.3 Nuclei
RPT-1::GFP fluorescence is enriched in the nucleus relative to the cytoplasm,
consistent with previous reports. In addition, we observed intensely fluorescent foci of
RPT-1::GFP within many nuclei that are decreased in number during egg-laying as
compared to young and older adults. It is possible that some of the nuclear foci are
aggregates of misfolded protein that sequester proteasomes. However, the foci are seen
under basal conditions without application of protein-folding stressors. Overexpressed
proteins expressed from transgenes can sometimes aggregate non-specifically, however,
the overall low levels of fluorescence in strain GS1 (relative to control GFP) as well as
the fact that the tightly-regulated process of proteasome biogenesis quickly degrades
unincorporated subunits (Kaneko et al., 2009) support the idea that the RPT-1::GFP is
biologically functional.
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Proteasomes are known to localize to nuclear foci that are associated with active
proteolysis (Chen et al., 2008; Rockel et al., 2005). PML bodies are nuclear bodies
involved in transcriptional regulation (Lallemand-Breitenbach & de Thé, 2010). They
recruit proteasomes and ubiquitin upon stress (Fabunmi et al., 2001; LallemandBreitenbach et al., 2008). Clastosomes are a type of PML body not associated with
chromatin, and are enriched in proteasomes, ubiquitin, and transcription factors. They
are detected infrequently, appearing in less than 20% of cells (Lafarga et al., 2002), with
each nucleus typically containing 1 or 2 clastosomes under non-stressed conditions.
Their formation increases during stress and is dependent on active proteolysis. Thus, it is
possible that some of the foci we see are clastosomes. However, many nuclei show far
more than 1 or 2 foci.
A caution one must consider in interpreting these results arises from the concept
of a dynamic proteasome composition that alters its subunit composition and associates
with accessory proteins. Thus, RPT-1::GFP may not be a precise indicator of ubiquitinmediated proteolysis. The base subcomplex of the 19S RP may be fulfilling normal roles
that do not involve proteasome-mediated proteolysis, many of which involve nuclear
functions.
A closer examination of DAPI-stained nuclei shows that (Figure 3.6) RPT-1::GFP
is excluded from regions of heterochromatin. Studies using more sensitive immunogold
electron microscopy show that proteasome regulatory subunits are localized to the
periphery of heterochromatic areas (Low et al., 2000; Rivett et al., 1992). A study of
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artificially-induced proteasome-containing proteolytic foci found that the foci formed
exclusively in euchromatic areas of the nucleus (Scharf et al., 2011).
The 19S subunit, particularly the base, has been observed to be involved in
transcription in a variety of ways. The base subcomplex, which includes RPT-1, is
known to be involved in transcriptional repression whereby the ATPase subunits of the
base destabilize the complex between an activator and DNA in an ATP-dependent manner
(Ferdous et al., 2007). 19S subcomplexes are recruited to promoters (Gonzalez et al.,
2002; Malik et al., 2009). RNA pol II also requires the 19S complex for efficient
elongation (Ferdous et al., 2001). As body wall muscle cells are post-mitotic, the wellestablished role of the UPS in regulating the cell cycle is not considered in this analysis
and changes in gene expression other than basal conditions should be considered in the
context of aging or physiological stress.
3.4.4 Aging
We observed several age-dependent changes in RPT-1::GFP localization.
Notably, there was a decrease in the number of nuclear RPT-1::GFP foci in egg-laying
adults as compared to younger or older adults.
We have previously observed a similar decrease in nuclear GFP::Ubiquitin foci at
an age of 3 days into adulthood (followed by a return to higher occurrence at 7 days) in a
different transgenic worm strain (Sanders, J. and Boyd, L., unpublished data).
Multiple reports indicate significant changes in protein quality control during
aging. This includes changes in the UPS early in adulthood. One group found that in the
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first 48 hours of adulthood, there is an increase in UPS activity in epithelial tissues that is
mediated by EGF signaling (Liu et al., 2011). This shifts the burden of protein quality
control from the chaperones to the UPS. While this shift was was not observed in muscle
cells, experiments using metastable muscle proteins indicated that there is a major
decrease in protein quality control early in adulthood in muscle cells (Ben-Zvi et al.,
2009). Numerous studies link changes in protein quality control with the early adulthood
(reviewed extensively in (Shai et al., 2014)). In addition, there are significant changes in
the transcription of many genes in early adulthood, including of those in muscle cells
(Lund et al., 2002). Thus, the change in foci levels we observed during reproduction
could represent a mobilization of existing proteasomes from a concentrated nuclear
region to a more diffuse mobile state, or a change in demand for the 19S subunit, as the
subunit composition of the proteasome and nuclear proteolytic activity is known to
change during aging (Rodriguez et al., 2010) and development (Low et al., 2000).
Alternatively, the change in foci levels in reproductive adults could represent
changes in transcription that are occuring during this critical time. The expression levels
of many genes changes early in adulthood (Lund et al., 2002). Some of these genes fit
into certain classes, such as heat shock proteins. Given that varied forms of the
proteasome are needed for transcription of different genes (Sikder et al., 2006), it is
possible that large RPT-1::GFP-containing sites of transcription are not needed during the
reproductive stage.
The finding here contributes to the timeline of events seen in the lifespan of C.
elegans. In particular, it provides clues to the role of the proteasome as organisms
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abandon the first-line defense mediated by chaperones and shift to higher degradative
activity. Further experiments examining in more detail the temporal and biochemical
composition of the nuclear foci would help to clarify the role of the proteasome in early
adulthood of C. elegans. In particular, it would be interesting to examine the structural
and biochemical differences between nuclear foci in older adults and younger adults.
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CHAPTER 4

PROTEASOME LOCALIZATION DURING DEVELOPMENT AND
STRESS

4.1 Introduction
4.1.1 Overview
Organisms must alter their cellular proteome in response to stressors that
challenge protein structure, and during the course of genetically programmed processes.
Multicellular organisms respond by coordinating information and commands via nervous
and endocrine signals, while at the subcellular level, cells alter patterns of gene
expression in response to the biological and physicochemical environment. Stressresponsive proteins such as chaperones and proteolytic enzymes may change in
abundance, location, or structure in order to perform their appropriate functions. Inability
to mount these responses may play a role in disease and aging. C. elegans, as a relatively
simple animal, with a small and defined number of cells, provides a useful model system
for studying both development and stress at multiple levels.
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4.1.2 Development and the UPS
The ubiquitin-proteasome system is essential for development in many organisms,
including plants (Moon et al., 2004), the frog Xenopus laevis (Iijima et al., 2003), and the
parasite Plasmodium falciparum (Lindenthal et al., 2005). In children, mutation of the
gene for the E3 ligase UBE3A results in Angelman syndrome (Mertz et al., 2014). RNAi
of many UPS genes in C. elegans results in embryonic lethality, including rpt-1
(Sönnichsen et al., 2005). The UPS is critical to the cell cycle. Early work with ovarian
granulosa cells (Amsterdam et al., 1993) showed proteasomes localized to foci
throughout the nucleus and cytoplasm, including the spindle apparatus, with an increase
in nuclear staining that occurred during mitosis, and changes during differentiation that
seemed to reflect the changing concentrations of cyclins during the cell cycle. It is wellestablished that myogenesis (formation of muscle) requires a precise temporal and spatial
arrangement of proteins, and evidence has recently emerged that the ubiquitinproteasome system is involved in muscle formation.
Ubiquitin-proteasome-mediated degradation of proteins plays a key role in muscle
growth and development. In cultured human skeletal myocytes, proteasome inhibition
alters the expression levels of multiple muscle-specific genes (Mugita et al., 1999). E3
ubiquitin ligases that are members of the MuRF (Muscle RING finger) family of proteins
are required for cardiac muscle development (Witt et al., 2008) and myofibrillogenesis
(Pizon et al., 2002), among many other functions. UNC-45, which serves as a chaperone
and co-chaperone to direct the assembly of myosin, must stay at an optimal level in order
to avoid sarcomere assembly defects. It is regulated by ubiquitination and proteasomal
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degradation (Hoppe et al., 2004; Landsverk et al., 2007). During C. elegans molting,
which occurs between larval stages, ubiquitination of adapter protein UNC-95 in dense
bodies plays a key role (Zaidel-Bar et al., 2010). Antibody staining against p27k, an αtype 20S subunit, shows diffuse cytoplasmic staining with positively stained deposits
around the nuclei (Foucrier et al., 2001). They suggest that that prosomes (proteasomes)
may be positioning mRNA during translation to aid in sarcomere assembly (Foucrier et
al., 2001). In insect wing muscle, a detailed immunogold localization study of various
proteasome subunits detected proteasome subunits in the contractile apparatus of
developing muscle, which change location during different phases of development (Low
et al., 2000).
4.1.3 Muscle Development in C. elegans
C. elegans contains 95 striated body wall muscle cells at adulthood, arranged in 4
quadrants of 24 or 25 cells (Figure 3.1). Rather than forming a continuous, multinucleate
myotube as in vertebrates, these spindle-shaped cells are attached to neighboring cells
and the hypodermis.
Muscle cell differentiation and sarcomere assembly begin in embryogenesis. The
first sarcomeres are added beginning at about 450 minutes after the first embronic
cleavage (Hresko et al., 1994), and muscle cells go from about 2 sarcomeres wide at
hatching to about 10 sarcomeres wide as an adult. After hatching, C. elegans larvae add
14 mononucleate body wall muscle cells to the 81 formed during embryogenesis (Sulston
& Horvitz, 1977).
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4.1.4 Stress Responses
Stress responses in C. elegans have been well-characterized. If hatched in the
absence of food, L1 larvae can enter a stress-resistant “L1 arrest” (Baugh, 2013). When
stressed in the presence of food, early larvae can enter the “dauer diapause”, a long-lived
state with altered morphology, metabolism, and behavior that can re-enter development at
the L4 stage upon relief of stress (Cassada & Russell, 1975). In adulthood, C. elegans
uses multiple pathways for resisting stress during reproduction and aging. The UPS plays
an important role in the cellular responses to these stressors.
SKN1, a transcription factor involved in the response to oxidative stress,
upregulates proteasome activity (Pickering et al., 2013). The transcription factor DAF16, which is part of a highly-conserved response that induces transcription of many
stress-response genes, upregulates the proteasome subunit rpn-6 to extend lifespan
(Vilchez et al., 2012), as well as downregulates expression of the deubiquitinating
enzyme ubh-4 (Matilainen et al., 2013). DAF-16 itself is regulated by ubiquitin-mediated
degradation (Li et al., 2007).
4.1.5 Heat Stress
The heat shock response (HSR), present in nearly all organisms, involves the
induction of many genes encoding heat shock proteins (HSPs). The transcription factors
HSF-1 and DAF-16 coordinate much of the heat shock response. This response can be
induced not only by heat, but by general stresses that induce protein misfolding,
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including heavy metal toxicity (Koizumi et al., 2013; Williams & Morimoto, 1990), and
proteasome inhibition (Bush et al., 1997). Upon application of stress, transcription factor
HSF-1 dissociates from the chaperone Hsp90, trimerizes, and drives expression of a
variety of genes that aid in the response to stress. The response to heat in C. elegans has
been shown to involve chaperones (Walker et al., 2001) increase lifespan (Lithgow et al.,
1995). While there is little evidence for upregulation of proteolysis-related genes in
higher eukaryotes after heat shock, it does induce a transient increase in ubiquitination of
cellular proteins (Parag et al., 1987).
Additionally, the UPS has been shown to be involved in the regulation of stress
responses. The transcription factor HIF-1α, which induces genes involved in the
response to hypoxia, is normally inhibited by proteasomeal degradation during nonstress-conditions (Salceda & Caro, 1997). DAF-16, a transcription factor that is central
to stress resistance and longevity, is ubiquitinated and degraded by the UPS (Li et al.,
2007).
Muscles must precisely adapt to a variety of stresses due to their high metabolic
requirements and complex ultrastructure. Oxidative stress can produce free radicals that
damage proteins, and contraction-relaxation cycles involve a relatively large degree of
mechanical force within the cell. Sarcomeres, the contractile units, must adapt to changes
in cell size that occur with growth, atrophy, or stress-induced remodeling. The
neuromuscular junction, the primary site for transmission of signals from the nervous
system to the muscle, must be carefully assembled and regulated. Given the importance
of the ubiquitin-proteasome system in protein quality control and gene transcription,
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examining the intracellular localization of proteasomes during stress may inform our
understanding of these responses. C. elegans’ large, transparent muscles, which possess
high similarity to vertebrate muscle, including cardiac muscle (Benian & Epstein, 2011),
are an effective model for microscopic analyses.
4.2 Methods
The strains were created as described in section 3.2.
4.2.1 Analysis of RPT-1::GFP during larval development
Worms of strain GS1 and GS3 were grown from a stock plate and allowed to lay
eggs. The set of mixed-stage larvae grown from these eggs were mounted on a
microscope slide and imaged using a 10X lens using a Zeiss Axio Observer.Z1 to
determine the larval stage based on size and morphology. For confocal imaging of GFP
in larvae, a 100X oil-immersion lens was used, and images were acquired with a Zeiss
LSM700 laser-scanning confocal unit.
4.2.2 Heat stress
Age-synchronized populations of GS1 and GS3 worms were obtained by washing
worms from populated plates and collecting L1 larvae by gravity sedimentation. Larvae
were placed on OP50-seeded NGM plates and incubated at 16°C to reproductive
adulthood, an age of 115 hours. NGM plates were then transferred to 30°C for 29 hours,
and examined on agarose-padded slides using a Zeiss Axio Observer.Z1 equipped with a
63X oil-immersion lens and a Zeiss LSM700 laser-scanning confocal unit. Z-stacks of
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whole fluorescent cells were acquired using a 488 nm laser for excitation of GFP and
collection of transmitted-light images.
For phenotype scoring, z-stack images of fluorescent cells were loaded in Zeiss
Zen (2.1) software and analyzed by viewing image slices at multiple Z-depths and by
viewing 3D projections created from the Z-stacks. Numbers of foci were counted per
nucleus, and a “yes” or “no” was recorded for each phenotype if present or not. Results
were tabulated in Microsoft Excel 2010.
4.3 RESULTS
4.3.1 RPT-1::GFP localization during larval development
To examine proteasome localization during development of C. elegans, we
observed RPT-1::GFP-expressing worms at each larval stage during incubation at 16ºC.
Figure 4.1 shows representative micrographs of RPT-1::GFP (left column) or control GFP
(right column) in the muscle belly and nucleus of larvae at each stage: L1, L2, L3, and
L4. Figure 4.2 shows shows a similar view for the contractile apparatus. Images in these
figures are representative of worms from each stage: L1: n=5 RPT-1::GFP, n=6 controls.
L2: n=4 RPT-1::GFP, n=4 controls. L3: n=5 RPT-1::GFP, n=3 controls. L4: n=5 RPT1::GFP. N=4 controls.
Within the nuclei of all stages, intensely fluorescent, punctate foci of RPT-1::GFP
are observed. Table 4.1 shows a count of the number of nuclei containing different
numbers of RPT-1::GFP foci. L2 larvae show higher numbers of nuclear foci than other
larval stages, and foci are seldom seen in the muscle belly cytoplasm outside of the
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nucleus. L4 larvae show fewer nuclear foci than other stages. Control GFP does not
form nuclear foci.

Figure 4.1: Localization of RPT-1::GFP in the nucleus at various stages of development.

Table 4.1: Number of RPT-1::GFP foci per nucleus during different larval stages for
strain GS1
Binning
0 foci
1 focus
2 foci
3-4 foci
5-8 foci
9-16 foci
More than 16 foci
Total Nuclei Observed

L1
10
4
3
11
9
4
0
41

L2
3
0
7
5
17
11
0
43

L3
6
2
5
15
10
3
0
41

L4
7
5
1
4
0
0
0
17

Mean foci per nucleus

3.5

5.7

3.7

1.2
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Throughout the contractile apparatus of body wall muscle cells in early larva,
many RPT-1::GFP foci are visible (Figure 4.2). The small size of larval muscle cells, and
dense patterning precludes accurate counting of foci, but a change in spatial patterning of
foci is observable during development. L1s show numerous irregularly-patterned foci
throughout the contractile apparatus, creating a granular appearance.

Figure 4.2: Localization of RPT-1::GFP in the contractile apparatus at various stages of
development.

To quantify the occurrence of and patterning of foci, cells in larvae of various
stages were examined for cytoplasmic (not nuclear) RPT-1::GFP localization pattern and
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phenotypes were tabulated and summarized in Table 4.2. Notably, the percentage of cells
showing irregularly-distributed foci is high in L1s but steadily decreases. As larvae
progress to the L4 stage, RPT-1::GFP is frequently seen forming foci on dense bodies,
creating a linear pattern of dots.

Table 4.2: Frequency of RPT-1::GFP cell phenotypes in the cytoplasm of larval GS1
worms
Larval stage
L1
L2
L3
L4

No Foci
2.7%, n=37 cells
7.7%, n=13
35.7%, n=28
0.0%, n=16

Irregular Foci
80.0%, n=40
66.7%, n=15
25.0%, n=28
25.0%, n=16

Regular Foci
63.4%, n=41
61.5%, n=13
50.0%, n=28
87.5%, n=16

To examine mobility of RPT-1::GFP in dense bodies of larvae, an RPT-1::GFPpositive dense body was bleached completely and allowed to recover. After a 3-second
bleach, no recovery of fluorescence was observed during a 7-minute recovery period
(Figure 4.3). This indicates that RPT-1::GFP in dense bodies does not rapidly exchange
with the cytoplasm and accumulates slowly in dense bodies.
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Figure 4.3: Photobleaching of RPT1::GFP in a dense body in an L4
larva.

4.3.2 Heat stress of RPT-1::GFP worms induces concentration of RPT-1::GFP to
dense bodies
An experiment was undertaken in which worms were subjected to heat stress for
12 or 29 hours at 30°C, then examined using confocal fluorescence microscopy. After 29
hours of heat shock, all RPT-1::GFP-positive muscle cells showed concentration of RPT1::GFP to intensely fluorescent foci that colocalized with dense bodies (Figure 4.4A, B;
Figure 4.5, Table 4.3), similar to what is sometimes observed in L4 larvae (Figure 4.2).
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In many cells, sarcomeres show a disordered patterning after heat shock (Figure 4.4B, F).
In 31% of control GFP worms, we observed a similar localization of fluorescence to
dense bodies, though the intensity relative to surrounding cytoplasm was less than with
RPT-1::GFP (Figure 4.4C, K). In some cases, control GFP worms showed exclusion of
GFP from dense bodies (Figure 4.4D, H, L). However, this variable localization with the
control GFP are also seen in non-heat-shocked worms. Images in Figures 4.4 and 4.5
were acquired using a 63X lens.

Figure 4.4: The spatial relationship between RPT-1::GFP and Dense Bodies in heatstressed C. elegans.
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Interestingly, the intense localization to dense bodies after heat shock is similar to
what is seen sporadically in cells in late L4 or young adult stages. However, heatstressed worms display this pattern in a binary manner: all sarcomeres in a cell display
RPT-1::GFP foci on dense bodies, or none do.

Figure 4.5: Localization of RPT-1::GFP to the dense bodies in the contractile apparatus
after heat stress at 30C for 29 hours.
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Table 4.3: Occurrence of RPT-1::GFP Phenotypes in heat-stressed worms
Foci on Dense Bodies

Exclusion from Dense Bodies

RPT-1::GFP, 12
hours heat stress

7.1%, n=14

57.1%, n=14

RPT-1::GFP, 29
hours heat stress

100.0%, n=11

18.2%, n=11

GFP Control, 29
hours heat stress

31.0%, n=29

41.4%, n=29

4.3.2.1 Photobleaching
To examine the mobility of proteasomes localized to dense bodies after heat
shock, we performed a FLIP experiment in which an RPT-1::GFP-positive dense body
was selectively photobleached every 6 seconds for a total of 3 minutes. Micrographs and
a quantification of fluorescence intensity are shown in Figure 4.6. Upper red rectangles
indicate the bleach region, while the lower red rectangle represents a nearby untargeted
dense body (“Proximal DB”). Panel A is a pre-bleach image, while Panel B shows the
cell after 180 seconds of repeated targeted bleaching. Panel C shows a quantification of
fluorescence of the bleached dense body, a nearby (proximal) dense body, a distant
(distal) dense body, normalized to the fluorescence intensity of a nearby neuron. No loss
of fluorescence was seen in neighboring dots, aside from normal photobleaching,
indicating a lack of exchange of material. However, no period longer than 6 seconds was
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observed without a bleach occuring. See Figure A.10 in Appendix A for a full view of
imaging setup.

Figure 4.6: FLIP Analysis of heat stress-induced RPT1::GFP focus on dense body.
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4.3.3 Proteasome activity in starved worms
During the course of optimizing experimental protocols for localization of
proteasome activity, a mixed population of starved RPT-1::GFP worms were stained with
the fluorogenic proteasome substrate MeOSuc-Phe-Leu-Phe-AFC. Interestingly,
treatment with this substrate showed an intense fluorescence localization to dense bodies
(Figure 4.7), indicating proteolytic activity at these structures. Images in Figure 4.7 are
representative of at least 5 cells in 4 different worms. In addition, the substrate is often
excluded from nuclei (Figure 4.8, representative of 5 different cells), despite the presence
of RPT-1::GFP fluorescence. It is likely that the substrate is being cleaved and
photobleached prior to diffusing into the nucleus. Similar exclusion from the nucleus has
been seen by another group (Rockel et al., 2005), following cytoplasmic injection of a
fluorogenic substrate.

Figure 4.7: Colocalization of fluorescent proteasome substrate with dense bodies.

107

Figure 4.8: Exclusion of fluorescent substrate from nucleus of body wall muscle cells in
starved worms.

4.4 Discussion
4.4.1 Larval Development
During all larval stages, we observed RPT-1::GFP fluorescence in the cytoplasm
and nucleus of body wall muscle cells. Notably, some RPT-1::GFP was concentrated to
irregularly-patterned, intensely fluorescent foci throughout the contractile apparatus and
nucleus. As the worms progressed from the L1 stage towards adulthood, the localization
pattern in the contractile apparatus became more regular, showing localization to dense
bodies, and foci within nuclei became lower in number.
4.4.1.1 Sarcomere growth
Sarcomeres, the basic contractile units of muscles, are still being assembled in
larvae (Moerman & Williams, 2006) and increase in size as cell size increases. A single
cell may contain 2 sarcomeres in a larva to 10 sarcomeres in an adult (Mackenzie et al.,
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1978). Since assembly of these complex structure requires precise arrangements of
protein fibers and attachment points, it is possible that large amounts of proteasome are
recruited in order to the contractile apparatus to aid in protein quality control. UNC-45, a
chaperone involved in regulating myosin fiber assembly, is itself tightly regulated by
proteasome-mediated degradation (Hoppe et al., 2004; Janiesch et al., 2007; Landsverk et
al., 2007). UNC-95, a LIM-domain protein critical to dense body structure and function,
is known to be ubiquitinated (Broday et al., 2004).
We propose that dense bodies may serve as hubs of ubiquitin-mediated
proteolysis, aiding in proteolysis for at least 2 major functions: remodeling of dense
body structure to adapt to growth and stress, and for degradation of excess myofibrillar
proteins.
4.4.1.2 UNC-45 and dense bodies
UNC-45 is a highly-conserved chaperone and co-chaperone that is essential for
myofibril assembly in C. elegans. Levels of UNC-45 must be finely tuned;
overexpression of UNC-45 leads to reduced thick filaments, while null mutations cause
embryonic arrest of body wall muscle development (Landsverk et al., 2007). UNC-45 is
degraded by the proteasome; thus, proteasomes are critical for muscle development by
controlling UNC-45 levels (Hoppe et al., 2004; Janiesch et al., 2007). It may be
beneficial for the cell to sequester proteasomes together into foci in the contractile
apparatus to rapidly respond to changes in UNC-45 levels. UNC-45 levels increase from
the L1 to L4 stages but are low in young adults, and most degradation of UNC-45 is
likely happening between the L4 and adult stage (Janiesch et al., 2007). Thus, the high
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degree of RPT-1::GFP foci in dense bodies in L4 worms may be a result of proteasomes
recruited to degrade UNC-45 at dense bodies. UNC-45 is a chaperone for myosin,
however, it has been shown in zebrafish to accumulate in Z-disks (the vertebrate analog
of dense bodies) and shuttle between the Z-disk and A-band (the location of myosin-actin
fiber overlap) during thermal or mechanical stress (Etard et al., 2008). Given that UNC45 regulates myosin levels by making it more prone to proteasome-mediated degradation,
it is tempting to propose that during development, UNC-45-associated myosin is
diffusing from A-bands to to dense bodies for rapid degradation.
Dense bodies are large, complex structures composed of many different proteins
serving various roles such as structure, signal transduction, and force transmission
(Lecroisey et al., 2007). Despite their role role in anchoring sarcomeres and in
maintaining the tension in contracting myofilaments, dense bodies and related integrinbased structures such as focal adhesions can be quite dynamic in their relationship as an
adapter between intracellular structures and extracellular attachment points. During
muscle development, dense bodies must be mobile within the plasma membrane in order
to allow for sarcomere growth.
4.4.1.3 RNF5 and UNC-95
The UPS is critical to regulating dense body dynamics. RNF5, a ubiquitin ligase,
ubiquitinates paxillin, a focal adhesion protein, to regulate cell motility in a human cell
line (Didier et al., 2003). Similarly, RNF-5 in C. elegans ubiquitinates UNC-95 (a LIM
domain protein similar to paxillin) in dense bodies during molting, at a time when dense
bodies are observed to be highly mobile within the cytoplasmic membrane. This
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ubiquitination is associated with a reduction of UNC-95 in dense bodies. A “clutch”
mechanism was proposed in which separation of the dense body from the hypodermis
allowed molting to occur without disrupting muscle structure (Zaidel-Bar et al., 2010).
While there is conflicting evidence as to whether ubiquitination of UNC-95 leads to its
proteasomal degradation, it cannot be ruled out, as RNF5 has been shown to be capable
of producing K48-linked polyubiquitin chains (Zhong et al., 2009). In further support of
proteolysis at dense bodies, we observed cleavage of the fluorogenic substrate
colocalized with dense bodies in starved worms. However, since these two stresses may
elicit differing responses, further experiments should be carried out to verify that dense
body-associated proteasomes are associated with active proteolysis.
4.4.1.4 Tethering Mechanism with UNC-95
While it is not clear that RNF-5-mediated ubiquitination leads to proteasomal
degradation of UNC-95, its localization to dense bodies may provide a mechanism for
tethering of proteasomes. A study of Xenopus laevis development found that Xenopus
protein XRNF185 binds both paxillin, a focal adhesion protein, via the N-terminus, and a
proteasome β-subunit via the C-terminus (Iioka et al., 2007). Focal adhesions are similar
to C. elegans dense bodies in structure and function (Cox & Hardin, 2004), and a search
for orthologs of XRNF185 in C. elegans revealed RNF-5 to have the most similar amino
acid sequence (39% identity). Much of the similarity between XRNF185 and RNF-5
occurs at the C-terminus (proteasome-binding) and at the N-terminal region
encompassing the RING finger. In C. elegans, RNF-5 has been shown microscopically to
localize to dense bodies (Broday et al., 2004), and to be partially immobilized within
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them (Ghosh & Hope, 2010). It has also been shown via co-immunoprecipitation to
interact with and ubiquitinate UNC-95, a C. elegans protein similar to paxillin, most
likely in cooperation with Ubc13 (Didier et al., 2003). This ubiquitination was not
observed to mediate degradation of paxillin, but did affect its subcellular localization.
Taken together, proteasome localization to dense bodies and the dynamic nature
of dense bodies during muscle development may explain some irregularities we observed
in the RPT-1::GFP foci. Assuming that the irregular foci correspond to dense bodies, the
patterning may be due to variations in sarcomere size early in larval development, as well
as the small, compact morphology of young body wall muscle cells. Irregular dense body
patterning may also account for disordered patterns of RPT-1::GFP-containing dense
bodies we observed in adult worms after prolonged heat stress. Further microscopy
experiments examining colocalization of RPT-1::GFP with a marker for dense body
component alpha-actinin, or a higher-resolution method such as immunoelectron
microscopy could verify that early RPT-1::GFP foci are associated with dense bodies in
early larvae.
Alternatively, the cytoplasmic foci we see may be polyribosomes. Proteasomes
are sometimes associated with polyribosomes (Kloetzel et al., 1987). Polyribosomes
have been shown to be localized along developing myofibrils in human skeletal muscle
(Larson et al., 1973), and may be involved in development of myosin filaments (Allen &
Terrence, 1968; Borisov et al., 2008) (Allen and Terrence 1968, Borisov 2008). As
muscle cells approach maturity, the need for polyribosomes in myofibrillogenesis may
decrease. Roles for ubiquitin-mediated proteolysis associated with translation have
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begun to emerge (Brandman et al., 2012; Dimitrova et al., 2009). However, it is not yet
clear if proteasomes localize to polyribosomes in sufficient concentration to account for
distinct fluorescent foci. Further colocalization experiments may answer this question.
4.4.2 Heat stress
Prolonged heat stress at 29°C induced a strong localization of RPT-1::GFP to
dense bodies. Given the multi-functional role of dense bodies, this localization could be
part of a number of processes, including protein quality control of heat-induced protein
misfolding, remodeling of attachments to allow for change in sarcomere length or cell
size, or signaling through the integrin proteins. Since we did not observe a response by
RPT-1::GFP to a shorter, 12 hour heat stress, it is likely that this proteasome
relocalization is part of a long-term adaptation to chronic stress.
Most cells initiate a heat shock response (HSR) following hyperthermia. Heatshocked body wall muscle cells in C. elegans have been shown to exhibit a rapid HSF-1
response that is less dependent on chaperones than in neurons (Kern et al., 2010), thus
may depend on various proteolytic systems, including the UPS. Heat stress of 30°C
results in reduced fertility in as little as 2 hours and complete sterility in about 8 hours
(Lithgow et al., 1994).
Chronic stress, however, may initiate a different response. In C. elegans, the AFD
sensory neurons can inhibit the HSR in body wall muscle cells during chronic stress via
dense core vesicle secretion (Prahlad & Morimoto, 2011), and may be able to store the
cultivation temperature and specifically respond to the rate of temperature change
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(Kimata et al., 2012). To re-eactivate the HSR response, acetylcholine signaling to body
wall muscle cells through L-type-acetylcholine receptors (L-AChRs), EGL-19, and
ryanodine receptors induces a calcium-mediated upregulation of the HSR in muscles
(Silva et al., 2013). Acetylcholine signaling can also inhibit UPS-mediated protein
degradation in these cells (Szewczyk et al., 2000). Thus, a complex set of signals
regulates a non-cell autonomous protein quality response to stress, which may initiate a
relocalization of proteasomes.
The sarcoplasmic reticulum of myocytes contains calcium that is released in
response to certain stimuli, including signals from motor neurons. In neurons, calcium
influx has been shown to alter proteasome localization by activating CaMKII, which
phosphorylates proteasomes (Djakovic et al., 2009), and acts as a scaffold to recruit them
to synaptic spines (Bingol & Schuman, 2006). Detergent-insolubility suggested that the
sequestered proteasomes may be associating with cytoskeletal proteins. Further work
showed that Rpt6, part of the 19S RP, was phosphorylated and that proteasome activity
was increased (Jarome et al., 2013). As dense bodies are closely associated with a variety
of cytoskeletal proteins, a similar sequestration mechanism may exist for muscle cells.
C. elegans possesses a single CamKII ortholog, unc-43 however, it is not clear that it is
expressed in muscle cells.
What is the biological purpose of sequestration of proteasomes to dense bodies?
If they are a center for protein quality control, it could provide for rapid degradation of
proteins that cannot be re-folded by chaperones. Dense bodies may be reservoirs for
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chaperones such UNC-45 (Etard et al., 2008), in which degradation would serve as a
second line of defense in the case of a non-refoldable protein.
If C. elegans alters its cell mass during stress, sarcomeres may be shortened or
removed. It has been shown that in smooth muscle cells, which are non-striated but
contain dense bodies similar to those in C. elegans, dense bodies help regulate the length
of actin cable (thin filaments) as cells change in size or tension (Zhang et al., 2010).
During loss of thin filaments in skeletal muscle, ubiquitination by the E3 ligase Trim32 is
critical for the degradation of actin, desmin, and the Z-disk-associated protein alphaactinin (Cohen et al., 2012).
Degradation of ryanodine receptors could be another plausible reason for RPT1::GFP localization to dense bodies. Ryanodine receptors are calcium channels that
mediate the release of calcium ions from the sarcoplasmic reticulum to the cytoplasm
during muscle contraction. In C. elegans, the sarcoplasmic reticulum extends from the
exterior of the cell into the contractile apparatus around dense bodies (Francis &
Waterston, 1985). The C. elegans ortholog of ryanodine receptor, UNC-68, and alphaactinin, the dense body component, show very similar localization patterns to that seen
with RPT-1::GFP foci (Lefebvre et al., 2016), and a regulatory subunit of the proteasome
has been shown to interact with ryanodine receptors in vertebrate skeletal muscle
(Mackrill, 1998). The regulatory role of proteasomes on ryanodine receptors has been
shown to occur during ischemia/reperfusion stress in rat cardiomyocytes (Pedrozo et al.,
2010), which could involve pathways shared with heat stress responses. While this
mechanism involves proteasomal degradation of calpastatins (and subsequent activation
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of calpains), which are absent in C. elegans, it is possible that an as yet unknown
mechanism links proteasomes with UNC-68 regulation.
Alternatively, muscle cells undergoing chronic heat stress may be undergoing
degeneration. Some cells in heat-shocked worms showed disordered dense body
arrangement, indicating that attachments mediated by dense bodies were mobile and
possibly weakened. Dying muscle cells in a C. elegans dystrophin mutant have shown to
have a lack of proper dense body patterning (Oh & Kim, 2013). It is possible that these
dense bodies are degrading as a part of cell death. Precedent for remodeling of cell
attachments exists with α-integrin in humans, which is known to be ubiquitinated by the
E3 ligase Cbl and subsequently degraded by the proteasome, weakening cell attachment
before apoptosis (Kaabeche et al., 2005).
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CHAPTER 5

CONCLUSIONS

5.1 Integrated view of Protein Quality Control

The ubiquitin-proteasome system is a single player in a complex web of
proteolytic and protein quality control systems. In terms of protein degradation, it
functions along side the autophagy-lysosome and caspase systems, after the front-line
defenses of the chaperone system. Evidence continues to show that there is a significant
degree of cross-talk between these systems, as well as regulation from multiple pathways
that convey signals from the environment and from other tissues of the organism. This
regulation and cross-talk allows a fine-tuned response in terms of which proteins are
degraded, at what rate, and at which location within the cell. Much of this regulation
manifests itself as alterations in proteasome subunit structure, such as the swapping of the
19S regulatory particle for alternative “caps”, or altering individual proteolytic subunits
within the 20S proteasome, as happens in response to IFN-γ signaling during an
inflammatory response. In addition, the location of proteasomes and even individual
subunits can be altered as needed. There is evidence that the 20S proteasome can
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function on its own to perform proteolysis in a way that is ubiquitin-independent. There
is also some evidence that parts of the 19S regulatory particle can function independently
of the degradative 20S proteasome, aiding in transcriptional regulation. As subunits in
the 19S RP contains varied functions including ATP-dependent protein unfolding,
translocation, and deubiquitination, it is unsurprising that evolution has co-opted some of
these modular functions for alternative use. Within the ubiquitin cascade, the full range
of functions of the E3 ubiquitin ligases remains to be explored; specifically, the
mechanisms regarding target protein selection and the construction of specific
ubiquitin/polyubiquitin topologies.
5.2 Future Directions
5.2.1 Improvements/extensions to Current Studies
A variety of studies using fluorescently-tagged proteasome subunits have shown
that these fusion proteins are efficiently incorporated into functional 26S proteasomes.
However, as mentioned before, the composition of the proteasome is dynamic. While
proteomic studies have been done to examine varying proteasome composition, it would
be useful to perform studies using multiple fluorescent subunits that are incorporated into
the varying forms of the proteasome holoenzyme. This would allow the observation of
changing proteasome composition in vivo in real-time. This strategy has been employed
in sensitive FRET experiments that produce a signal when two proteasome subunits are
closely associated (Park et al., 2014).
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These experiments could be expanded to demonstrate proteasomal responses to a
wider variety of cellular stresses beyond heat shock. Oxidation, UV radiation, starvation,
and heavy metal toxicity have all been shown to alter protein homeostasis and would be
easy to apply to C. elegans.
Several strategies could be employed to better examine proteasome dynamics
during aging. As RPT-1::GFP expression was very low in old worms, a promoter that
remains highly active during aging would be more useful for driving expression of the
transgene. Alternatively, the GFP ORF could be fused directly to the genomic rpt-1 ORF
using CRISPR, allowing expression patterns that would be similar to the endogenous
form.
In the aggregation study, we used the Q82::GFP fusion protein, which contains 82
glutamines. This protein is extremely aggregation-prone, as it is far beyond the ~40-mer
threshold for aggregation that results in Huntington’s disease. A more sensitive readout
of altered aggregation susceptibility could be accomplished by using a Q40 fusion
protein. Worms expressing this fusion protein in body wall muscle cells have been
shown to slowly accumulate aggregates throughout a long period of the lifespan, which
may better approximate human diseases of aging.
We did not examine aggregate formation in older worms. Improving the
observation method to better accommodate adult worms would allow us to do this. It
would be interesting to compare formation data between larvae and adults.
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Proteomic studies of isolated aggregates would be highly useful in examining the
ubiquitination status of various aggregate-associated proteins. Microdissection of
aggregates followed by mass spectrometry has previously been used to obtain specific
proteomic data on aggregated proteins (Feldkirchner et al., 2012).
5.2.2 Applications
Proteasome inhibitors are currently approved for treatment of certain cancers. In
addition to disrupting the highly UPS-dependent cell cycle progression, PQC systems in
these cells may be near-capacity as a high number of mutations and high metabolic
activity create a heavy load of misfolded proteins. A better understanding of the
subcellular spatial dynamics of proteasomes in the various cellular compartments may
inform the development of more precise proteasome-targeting pharmaceuticals, reducing
off-target effects.
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APPENDIX A

SUPPLEMENTAL DATA

Figure A.1: Photobleaching of Q82::GFP shows similarity between newlyformed and pre-existing aggregates.
Bleaching occurs after the 2nd data point. n=5 for each group.
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Figure A.2: Percent of nucleolus phenotype in RPT-1::GFP-expressing worms of
various ages incubated at 16ºC.
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Figure A.3: Percent of each vacuolation phenotype for body wall muscle cells in RPT1::GFP-expressing worms of various ages incubated at 16ºC
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Figure A.4: Heat-stressed worm showing fluorescent RPT-1::GFP foci on dense bodies.
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Figure A.5: Photomicrographs of RPT-1::GFP-expressing muscle cells in C. elegans
demonstrating FLIP experiments.
Panels A and F show portions of muscle cells and worm body in strain GS1a (Panel A)
and strain GS3a (Panel E) with bleaching target region (red boxes), non-bleached regions
for FLIP analysis (yellow boxes), and control regions in neighboring cells not receiving
targeted bleaches (cyan boxes). Smaller panels show magnified view of nuclei for GS1
(Panels B-E, and GS3 (Panels G-J) with arrows pointing to bleach regions The 5 µm
scale bars apply to all small panels.
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Figure A.6: Diagram indicating regions of interest in FLIP experiments in body wall
muscle cells.
A body wall muscle cell (large green spindle-shaped object in cartoon) was selected and a
region within the nucleus (bleach region) was bleached every 10 seconds at 100% power.
An area of distal nucleoplasm (DN), "nuclear dot" (ND), the Nucleolus (N), Perinuclear
cytoplasm (PN C), and distal cytoplasm (DC) were chosen for fluorescence analysis.
Control regions in neighboring cells were measured to control for acquisition
photobleaching and to calculate Relative Fluorescence Intensity (RFI) of other regions.
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Figure A.7: Relative Fluorescence Intensity (RFI) of the bleach region and a distal region
of nucleoplasm for strains GS1a and GS3a during FLIP experiments.
Fluorescence decreases rapidly in the bleach region of GS1a worms to ~20% intensity
within about a minute, while bleaching GFP in GS3a worms yields a much slower loss of
intensity that does not decrease to 20% intensity even at 5 minutes of observation time.
This indicates that RPT-1::GFP is less mobile than the control GFP. In addition, distal
regions of the nucleus lose intensity faster in GS3a worms than for GS21a worms,
indicating that the control GFP, as expected, exchanges more rapidly throughout the
nucleoplasm.
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Figure A.8: RFI in Perinuclear cytoplasm and Distal Cytoplasm during FLIP
experiments.
Fluorescence loss in cytoplasm. This shows that for the time-scales involved in this
experiment, RPT-1::GFP is not exchanging with the cytoplasm in an observable way, as
perinuclear regions show little or no decrease in fluorescence. Perinuclear regions in
GS3 worms lose fluorescence, though more slowly than the bleach region and slightly
more slowly than intranuclear regions, indicating that GFP can move across the nuclear
membrane. In GS1a worms, little to no change was seen in distal cytoplasm regions,
further confirming the lack of mobility of RPT-1::GFP, while similar regions in GS3a
worms showed a loss of fluorescence that parallels what is seen in perinuclear cytoplasm
of the same region, indicating mobility of GFP within the cytoplasm (as expected).
128

Figure A.9: RFI in Nuclear Dot and Nucleolus during FLIP experiments.
RPT-1::GFP in the nucleolus showed a loss of fluorescence similar to other regions of the
nucleus, much slower than the bleach region, while GFP in the nucleolus appeared to
exchange more rapidly with GFP in the nucleoplasm. When a "nuclear dot", or the
brightest region in the nucleus was observed, fluorescence intensity decreased at a rate
slightly faster than other nuclear regions. For GS3 control worms, the rate was similar to
that of the bleach region, indicating rapid diffusion of GFP within the nucleus.
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Figure A.10: Overview of FLIP analysis of heat-stress-induced dense body
localization of RPT-1::GFP.
DB = Dense Body.
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Figure A.11: Image of worm stained with a proteasome inhibitor (MG132) and
proteasome substrate.
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